WO2010080618A2 - Porous reactive frameworks - Google Patents
Porous reactive frameworks Download PDFInfo
- Publication number
- WO2010080618A2 WO2010080618A2 PCT/US2009/068731 US2009068731W WO2010080618A2 WO 2010080618 A2 WO2010080618 A2 WO 2010080618A2 US 2009068731 W US2009068731 W US 2009068731W WO 2010080618 A2 WO2010080618 A2 WO 2010080618A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- framework
- zif
- group
- post
- reactive
- Prior art date
Links
- 239000013354 porous framework Substances 0.000 claims abstract description 19
- 125000005647 linker group Chemical group 0.000 claims description 62
- 238000000034 method Methods 0.000 claims description 59
- 238000006243 chemical reaction Methods 0.000 claims description 33
- 125000000623 heterocyclic group Chemical group 0.000 claims description 26
- 239000011148 porous material Substances 0.000 claims description 24
- 125000004429 atom Chemical group 0.000 claims description 23
- 125000003118 aryl group Chemical group 0.000 claims description 21
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- 239000000376 reactant Substances 0.000 claims description 18
- 229910052757 nitrogen Inorganic materials 0.000 claims description 16
- 229910052698 phosphorus Inorganic materials 0.000 claims description 16
- 229910052717 sulfur Inorganic materials 0.000 claims description 14
- 229910052751 metal Inorganic materials 0.000 claims description 12
- 239000002184 metal Substances 0.000 claims description 12
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 12
- 238000001179 sorption measurement Methods 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 9
- 230000004048 modification Effects 0.000 claims description 8
- 238000012986 modification Methods 0.000 claims description 8
- 150000001412 amines Chemical class 0.000 claims description 7
- 229910052794 bromium Inorganic materials 0.000 claims description 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 7
- 229910052731 fluorine Inorganic materials 0.000 claims description 7
- 125000000524 functional group Chemical group 0.000 claims description 7
- 229910052740 iodine Inorganic materials 0.000 claims description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 6
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 6
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 6
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims description 5
- 150000002391 heterocyclic compounds Chemical class 0.000 claims description 5
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 125000005842 heteroatom Chemical group 0.000 claims description 4
- 125000002524 organometallic group Chemical group 0.000 claims description 4
- VDFVNEFVBPFDSB-UHFFFAOYSA-N 1,3-dioxane Chemical compound C1COCOC1 VDFVNEFVBPFDSB-UHFFFAOYSA-N 0.000 claims description 3
- CZLMRJZAHXYRIX-UHFFFAOYSA-N 1,3-dioxepane Chemical compound C1CCOCOC1 CZLMRJZAHXYRIX-UHFFFAOYSA-N 0.000 claims description 3
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 claims description 3
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 claims description 3
- FQUYSHZXSKYCSY-UHFFFAOYSA-N 1,4-diazepane Chemical compound C1CNCCNC1 FQUYSHZXSKYCSY-UHFFFAOYSA-N 0.000 claims description 3
- YHCUZRJTNSWYCY-UHFFFAOYSA-N 2,3,4,7-tetrahydro-1h-azepine Chemical compound C1CNCC=CC1 YHCUZRJTNSWYCY-UHFFFAOYSA-N 0.000 claims description 3
- OZIJESHLNXSUNE-UHFFFAOYSA-N 2,3-dihydrofuran;thiolane 1,1-dioxide Chemical compound C1CC=CO1.O=S1(=O)CCCC1 OZIJESHLNXSUNE-UHFFFAOYSA-N 0.000 claims description 3
- GSUPYHWEFVSXBA-UHFFFAOYSA-N 2,5-dihydrofuran;oxolane Chemical compound C1CCOC1.C1OCC=C1 GSUPYHWEFVSXBA-UHFFFAOYSA-N 0.000 claims description 3
- JECYNCQXXKQDJN-UHFFFAOYSA-N 2-(2-methylhexan-2-yloxymethyl)oxirane Chemical compound CCCCC(C)(C)OCC1CO1 JECYNCQXXKQDJN-UHFFFAOYSA-N 0.000 claims description 3
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 claims description 3
- MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 claims description 3
- FTAHXMZRJCZXDL-UHFFFAOYSA-N 3-piperideine Chemical compound C1CC=CCN1 FTAHXMZRJCZXDL-UHFFFAOYSA-N 0.000 claims description 3
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 claims description 3
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 claims description 3
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 150000004982 aromatic amines Chemical class 0.000 claims description 3
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 claims description 3
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000013522 chelant Substances 0.000 claims description 3
- UHHKSVZZTYJVEG-UHFFFAOYSA-N oxepane Chemical compound C1CCCOCC1 UHHKSVZZTYJVEG-UHFFFAOYSA-N 0.000 claims description 3
- AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 claims description 3
- USPWKWBDZOARPV-UHFFFAOYSA-N pyrazolidine Chemical compound C1CNNC1 USPWKWBDZOARPV-UHFFFAOYSA-N 0.000 claims description 3
- DNXIASIHZYFFRO-UHFFFAOYSA-N pyrazoline Chemical compound C1CN=NC1 DNXIASIHZYFFRO-UHFFFAOYSA-N 0.000 claims description 3
- ZVJHJDDKYZXRJI-UHFFFAOYSA-N pyrroline Natural products C1CC=NC1 ZVJHJDDKYZXRJI-UHFFFAOYSA-N 0.000 claims description 3
- 125000000542 sulfonic acid group Chemical group 0.000 claims description 3
- RAOIDOHSFRTOEL-UHFFFAOYSA-N tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 claims description 3
- XSROQCDVUIHRSI-UHFFFAOYSA-N thietane Chemical compound C1CSC1 XSROQCDVUIHRSI-UHFFFAOYSA-N 0.000 claims description 3
- VOVUARRWDCVURC-UHFFFAOYSA-N thiirane Chemical compound C1CS1 VOVUARRWDCVURC-UHFFFAOYSA-N 0.000 claims description 3
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 claims description 3
- IBBLKSWSCDAPIF-UHFFFAOYSA-N thiopyran Chemical compound S1C=CC=C=C1 IBBLKSWSCDAPIF-UHFFFAOYSA-N 0.000 claims description 3
- FSSPGSAQUIYDCN-UHFFFAOYSA-N 1,3-Propane sultone Chemical compound O=S1(=O)CCCO1 FSSPGSAQUIYDCN-UHFFFAOYSA-N 0.000 claims description 2
- OZDGMOYKSFPLSE-UHFFFAOYSA-N 2-Methylaziridine Chemical compound CC1CN1 OZDGMOYKSFPLSE-UHFFFAOYSA-N 0.000 claims description 2
- 230000007704 transition Effects 0.000 claims description 2
- 238000007306 functionalization reaction Methods 0.000 abstract description 9
- 239000003814 drug Substances 0.000 abstract description 3
- 238000000926 separation method Methods 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 60
- -1 carboline Chemical compound 0.000 description 34
- 239000013078 crystal Substances 0.000 description 32
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 28
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 25
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 24
- 0 CC(*)[C@](C)[Si](c1ccc(*)cc1)(c1ccc(*)cc1)c1ccc(*)cc1 Chemical compound CC(*)[C@](C)[Si](c1ccc(*)cc1)(c1ccc(*)cc1)c1ccc(*)cc1 0.000 description 20
- 239000013310 covalent-organic framework Substances 0.000 description 20
- 238000001144 powder X-ray diffraction data Methods 0.000 description 20
- 229910052723 transition metal Inorganic materials 0.000 description 19
- 150000003624 transition metals Chemical group 0.000 description 19
- 239000012621 metal-organic framework Substances 0.000 description 18
- 239000002904 solvent Substances 0.000 description 18
- 239000007789 gas Substances 0.000 description 17
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 17
- 229910052760 oxygen Inorganic materials 0.000 description 16
- 150000001299 aldehydes Chemical class 0.000 description 15
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 15
- 239000001301 oxygen Substances 0.000 description 15
- 239000013153 zeolitic imidazolate framework Substances 0.000 description 15
- 229910002092 carbon dioxide Inorganic materials 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000013626 chemical specie Substances 0.000 description 12
- 241000894007 species Species 0.000 description 12
- 239000001569 carbon dioxide Substances 0.000 description 11
- JBFYUZGYRGXSFL-UHFFFAOYSA-N imidazolide Chemical compound C1=C[N-]C=N1 JBFYUZGYRGXSFL-UHFFFAOYSA-N 0.000 description 11
- 239000003345 natural gas Substances 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 239000011701 zinc Substances 0.000 description 11
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 9
- 229910052799 carbon Inorganic materials 0.000 description 9
- 150000002466 imines Chemical group 0.000 description 9
- 239000013384 organic framework Substances 0.000 description 9
- 239000011574 phosphorus Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000005481 NMR spectroscopy Methods 0.000 description 8
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000011593 sulfur Substances 0.000 description 8
- 238000004482 13C cross polarization magic angle spinning Methods 0.000 description 7
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 7
- KHRXNVYXJMVOBM-UHFFFAOYSA-N [amino(nitro)boranyl]formonitrile Chemical compound N#CB(N)[N+]([O-])=O KHRXNVYXJMVOBM-UHFFFAOYSA-N 0.000 description 7
- 125000003545 alkoxy group Chemical group 0.000 description 7
- 150000001408 amides Chemical class 0.000 description 7
- 229910052796 boron Inorganic materials 0.000 description 7
- 150000001735 carboxylic acids Chemical class 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- 229910052736 halogen Inorganic materials 0.000 description 7
- 150000002367 halogens Chemical class 0.000 description 7
- 238000006053 organic reaction Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 150000001336 alkenes Chemical class 0.000 description 6
- 150000001345 alkine derivatives Chemical class 0.000 description 6
- 150000002576 ketones Chemical class 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 238000006467 substitution reaction Methods 0.000 description 6
- 125000005309 thioalkoxy group Chemical group 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 238000005004 MAS NMR spectroscopy Methods 0.000 description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 5
- 229910052786 argon Inorganic materials 0.000 description 5
- 238000013480 data collection Methods 0.000 description 5
- 125000006575 electron-withdrawing group Chemical group 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000005855 radiation Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- 229910052710 silicon Inorganic materials 0.000 description 5
- 239000010703 silicon Substances 0.000 description 5
- 238000000844 transformation Methods 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 4
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 4
- 229910002651 NO3 Inorganic materials 0.000 description 4
- QGJOPFRUJISHPQ-UHFFFAOYSA-N carbon disulfide Substances S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000009833 condensation Methods 0.000 description 4
- 230000005494 condensation Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 125000001072 heteroaryl group Chemical group 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229910052697 platinum Inorganic materials 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 239000012279 sodium borohydride Substances 0.000 description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 3
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 3
- 229910002483 Cu Ka Inorganic materials 0.000 description 3
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 3
- 229910052766 Lawrencium Inorganic materials 0.000 description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 3
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 125000003158 alcohol group Chemical group 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- XSCHRSMBECNVNS-UHFFFAOYSA-N benzopyrazine Natural products N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 3
- 229910021475 bohrium Inorganic materials 0.000 description 3
- 229910052793 cadmium Inorganic materials 0.000 description 3
- 229910002091 carbon monoxide Inorganic materials 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- 229910052804 chromium Inorganic materials 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000002178 crystalline material Substances 0.000 description 3
- 125000004093 cyano group Chemical group *C#N 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical group O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 229910021473 hassium Inorganic materials 0.000 description 3
- 150000002430 hydrocarbons Chemical group 0.000 description 3
- 229910052741 iridium Inorganic materials 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 229910052748 manganese Inorganic materials 0.000 description 3
- 229910052753 mercury Inorganic materials 0.000 description 3
- 229910052750 molybdenum Inorganic materials 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 229910052758 niobium Inorganic materials 0.000 description 3
- 229910052762 osmium Inorganic materials 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- 125000003367 polycyclic group Chemical group 0.000 description 3
- 125000004585 polycyclic heterocycle group Chemical group 0.000 description 3
- 238000012987 post-synthetic modification Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 229910052702 rhenium Inorganic materials 0.000 description 3
- 229910052703 rhodium Inorganic materials 0.000 description 3
- 229910052707 ruthenium Inorganic materials 0.000 description 3
- 229910021481 rutherfordium Inorganic materials 0.000 description 3
- 229910052706 scandium Inorganic materials 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000002594 sorbent Substances 0.000 description 3
- 229910052715 tantalum Inorganic materials 0.000 description 3
- 229910052713 technetium Inorganic materials 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 229910052721 tungsten Inorganic materials 0.000 description 3
- 229910052720 vanadium Inorganic materials 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- 229910052727 yttrium Inorganic materials 0.000 description 3
- 229910052726 zirconium Inorganic materials 0.000 description 3
- ZWAJLVLEBYIOTI-OLQVQODUSA-N (1s,6r)-7-oxabicyclo[4.1.0]heptane Chemical compound C1CCC[C@@H]2O[C@@H]21 ZWAJLVLEBYIOTI-OLQVQODUSA-N 0.000 description 2
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 2
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 2
- HBEDSQVIWPRPAY-UHFFFAOYSA-N 2,3-dihydrobenzofuran Chemical compound C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 description 2
- BAKUAUDFCNFLBX-UHFFFAOYSA-N 4,7-dihydro-1,3-dioxepine Chemical compound C1OCC=CCO1 BAKUAUDFCNFLBX-UHFFFAOYSA-N 0.000 description 2
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 238000004566 IR spectroscopy Methods 0.000 description 2
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical compound C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 238000005384 cross polarization magic-angle spinning Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 239000003949 liquefied natural gas Substances 0.000 description 2
- 208000020442 loss of weight Diseases 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 229910052665 sodalite Inorganic materials 0.000 description 2
- 238000004729 solvothermal method Methods 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 2
- QMLILIIMKSKLES-UHFFFAOYSA-N triphenylene-2,3,6,7,10,11-hexol Chemical group C12=CC(O)=C(O)C=C2C2=CC(O)=C(O)C=C2C2=C1C=C(O)C(O)=C2 QMLILIIMKSKLES-UHFFFAOYSA-N 0.000 description 2
- 238000001622 two pulse phase modulation pulse sequence Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 208000016261 weight loss Diseases 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- SFYBRCJPMDQKHA-UHFFFAOYSA-N zinc;dinitrate;tetrahydrate Chemical compound O.O.O.O.[Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O SFYBRCJPMDQKHA-UHFFFAOYSA-N 0.000 description 2
- 125000004502 1,2,3-oxadiazolyl group Chemical group 0.000 description 1
- UGUHFDPGDQDVGX-UHFFFAOYSA-N 1,2,3-thiadiazole Chemical compound C1=CSN=N1 UGUHFDPGDQDVGX-UHFFFAOYSA-N 0.000 description 1
- 125000004511 1,2,3-thiadiazolyl group Chemical group 0.000 description 1
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 description 1
- BBVIDBNAYOIXOE-UHFFFAOYSA-N 1,2,4-oxadiazole Chemical compound C=1N=CON=1 BBVIDBNAYOIXOE-UHFFFAOYSA-N 0.000 description 1
- 125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 description 1
- YGTAZGSLCXNBQL-UHFFFAOYSA-N 1,2,4-thiadiazole Chemical compound C=1N=CSN=1 YGTAZGSLCXNBQL-UHFFFAOYSA-N 0.000 description 1
- 125000004514 1,2,4-thiadiazolyl group Chemical group 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- KTZQTRPPVKQPFO-UHFFFAOYSA-N 1,2-benzoxazole Chemical compound C1=CC=C2C=NOC2=C1 KTZQTRPPVKQPFO-UHFFFAOYSA-N 0.000 description 1
- AVGHIQUXSVAJBC-UHFFFAOYSA-N 1,2-diazabicyclo[2.2.1]heptane Chemical compound C1C2CCN1NC2 AVGHIQUXSVAJBC-UHFFFAOYSA-N 0.000 description 1
- FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical compound C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 description 1
- 125000001781 1,3,4-oxadiazolyl group Chemical group 0.000 description 1
- MBIZXFATKUQOOA-UHFFFAOYSA-N 1,3,4-thiadiazole Chemical compound C1=NN=CS1 MBIZXFATKUQOOA-UHFFFAOYSA-N 0.000 description 1
- 125000004520 1,3,4-thiadiazolyl group Chemical group 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- IGERFAHWSHDDHX-UHFFFAOYSA-N 1,3-dioxanyl Chemical group [CH]1OCCCO1 IGERFAHWSHDDHX-UHFFFAOYSA-N 0.000 description 1
- 125000005877 1,4-benzodioxanyl group Chemical group 0.000 description 1
- 125000005940 1,4-dioxanyl group Chemical group 0.000 description 1
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 1
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
- TZMSYXZUNZXBOL-UHFFFAOYSA-N 10H-phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 description 1
- 238000004922 13C solid-state nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- AAQTWLBJPNLKHT-UHFFFAOYSA-N 1H-perimidine Chemical compound N1C=NC2=CC=CC3=CC=CC1=C32 AAQTWLBJPNLKHT-UHFFFAOYSA-N 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- UXGVMFHEKMGWMA-UHFFFAOYSA-N 2-benzofuran Chemical compound C1=CC=CC2=COC=C21 UXGVMFHEKMGWMA-UHFFFAOYSA-N 0.000 description 1
- 239000013473 2D covalent-organic framework Substances 0.000 description 1
- VHMICKWLTGFITH-UHFFFAOYSA-N 2H-isoindole Chemical compound C1=CC=CC2=CNC=C21 VHMICKWLTGFITH-UHFFFAOYSA-N 0.000 description 1
- VMUXSMXIQBNMGZ-UHFFFAOYSA-N 3,4-dihydrocoumarin Chemical compound C1=CC=C2OC(=O)CCC2=C1 VMUXSMXIQBNMGZ-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- 239000013476 3D covalent-organic framework Substances 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- NKLOLMQJDLMZRE-UHFFFAOYSA-N 6-chloro-1h-benzimidazole Chemical compound ClC1=CC=C2N=CNC2=C1 NKLOLMQJDLMZRE-UHFFFAOYSA-N 0.000 description 1
- YPWFNLSXQIGJCK-UHFFFAOYSA-N 7-oxabicyclo[2.2.1]heptane Chemical compound C1CC2CCC1O2 YPWFNLSXQIGJCK-UHFFFAOYSA-N 0.000 description 1
- 125000005941 7-oxabicyclo[2.2.1]heptyl group Chemical group 0.000 description 1
- PQJUJGAVDBINPI-UHFFFAOYSA-N 9H-thioxanthene Chemical compound C1=CC=C2CC3=CC=CC=C3SC2=C1 PQJUJGAVDBINPI-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 229910016962 As(SH)3 Inorganic materials 0.000 description 1
- 229910017252 AsO3H Inorganic materials 0.000 description 1
- 229910017258 AsO4H Inorganic materials 0.000 description 1
- 238000004438 BET method Methods 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- KHYPCMPLHCOVLX-UHFFFAOYSA-N C[N]1(C)OCCC1 Chemical compound C[N]1(C)OCCC1 KHYPCMPLHCOVLX-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 229910005942 Ge(OH)3 Inorganic materials 0.000 description 1
- 229910005927 Ge(SH)4 Inorganic materials 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241001508691 Martes zibellina Species 0.000 description 1
- ITAAUGIIVOQSTJ-UHFFFAOYSA-N Oc(cc(c(c1c2)c3)c(cc(c(O)c4)O)c4c1cc(O)c2O)c3N=O Chemical compound Oc(cc(c(c1c2)c3)c(cc(c(O)c4)O)c4c1cc(O)c2O)c3N=O ITAAUGIIVOQSTJ-UHFFFAOYSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- 229910004841 P(SH)3 Inorganic materials 0.000 description 1
- 229910018830 PO3H Inorganic materials 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 229910006069 SO3H Inorganic materials 0.000 description 1
- 229910007157 Si(OH)3 Inorganic materials 0.000 description 1
- 229910007215 Si(SH)4 Inorganic materials 0.000 description 1
- 229910009241 Sn(SH)4 Inorganic materials 0.000 description 1
- 239000006180 TBST buffer Substances 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical group [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 125000004069 aziridinyl group Chemical group 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- BNBQRQQYDMDJAH-UHFFFAOYSA-N benzodioxan Chemical compound C1=CC=C2OCCOC2=C1 BNBQRQQYDMDJAH-UHFFFAOYSA-N 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 125000004623 carbolinyl group Chemical group 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 238000001875 carbon-13 cross-polarisation magic angle spinning nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical compound C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 description 1
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 description 1
- QZHPTGXQGDFGEN-UHFFFAOYSA-N chromene Chemical compound C1=CC=C2C=C[CH]OC2=C1 QZHPTGXQGDFGEN-UHFFFAOYSA-N 0.000 description 1
- 125000004230 chromenyl group Chemical group O1C(C=CC2=CC=CC=C12)* 0.000 description 1
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 125000000332 coumarinyl group Chemical group O1C(=O)C(=CC2=CC=CC=C12)* 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 238000005388 cross polarization Methods 0.000 description 1
- 239000002181 crystalline organic material Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- DMSHWWDRAYHEBS-UHFFFAOYSA-N dihydrocoumarin Natural products C1CC(=O)OC2=C1C=C(OC)C(OC)=C2 DMSHWWDRAYHEBS-UHFFFAOYSA-N 0.000 description 1
- 125000000532 dioxanyl group Chemical group 0.000 description 1
- 125000005879 dioxolanyl group Chemical group 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000002592 echocardiography Methods 0.000 description 1
- 238000000119 electrospray ionisation mass spectrum Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000002737 fuel gas Substances 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- JKFAIQOWCVVSKC-UHFFFAOYSA-N furazan Chemical compound C=1C=NON=1 JKFAIQOWCVVSKC-UHFFFAOYSA-N 0.000 description 1
- 125000003838 furazanyl group Chemical group 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 239000002638 heterogeneous catalyst Substances 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- HOBCFUWDNJPFHB-UHFFFAOYSA-N indolizine Chemical compound C1=CC=CN2C=CC=C21 HOBCFUWDNJPFHB-UHFFFAOYSA-N 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- 125000001977 isobenzofuranyl group Chemical group C=1(OC=C2C=CC=CC12)* 0.000 description 1
- HEBMCVBCEDMUOF-UHFFFAOYSA-N isochromane Chemical compound C1=CC=C2COCCC2=C1 HEBMCVBCEDMUOF-UHFFFAOYSA-N 0.000 description 1
- 125000003384 isochromanyl group Chemical group C1(OCCC2=CC=CC=C12)* 0.000 description 1
- GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical compound C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 description 1
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- SNVLJLYUUXKWOJ-UHFFFAOYSA-N methylidenecarbene Chemical group C=[C] SNVLJLYUUXKWOJ-UHFFFAOYSA-N 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000003566 oxetanyl group Chemical group 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 125000005327 perimidinyl group Chemical group N1C(=NC2=CC=CC3=CC=CC1=C23)* 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 125000004934 phenanthridinyl group Chemical group C1(=CC=CC2=NC=C3C=CC=CC3=C12)* 0.000 description 1
- 125000004625 phenanthrolinyl group Chemical group N1=C(C=CC2=CC=C3C=CC=NC3=C12)* 0.000 description 1
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- GJSGGHOYGKMUPT-UHFFFAOYSA-N phenoxathiine Chemical compound C1=CC=C2OC3=CC=CC=C3SC2=C1 GJSGGHOYGKMUPT-UHFFFAOYSA-N 0.000 description 1
- 125000005954 phenoxathiinyl group Chemical group 0.000 description 1
- 125000001644 phenoxazinyl group Chemical group C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000013309 porous organic framework Substances 0.000 description 1
- 238000000634 powder X-ray diffraction Methods 0.000 description 1
- CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- LJPZHJUSICYOIX-UHFFFAOYSA-N quinolizidine Chemical compound C1CCCC2CCCCN21 LJPZHJUSICYOIX-UHFFFAOYSA-N 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical compound C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 description 1
- 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000004467 single crystal X-ray diffraction Methods 0.000 description 1
- 238000000373 single-crystal X-ray diffraction data Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 238000002411 thermogravimetry Methods 0.000 description 1
- GVIJJXMXTUZIOD-UHFFFAOYSA-N thianthrene Chemical compound C1=CC=C2SC3=CC=CC=C3SC2=C1 GVIJJXMXTUZIOD-UHFFFAOYSA-N 0.000 description 1
- 125000004627 thianthrenyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3SC12)* 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000002053 thietanyl group Chemical group 0.000 description 1
- 125000001730 thiiranyl group Chemical group 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 125000001834 xanthenyl group Chemical group C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Inorganic materials [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages
Definitions
- This disclosure relates to porous frameworks for gas separation, sensing and drug/biomolecule delivery. More particularly, the disclosure relates to reactive porous frameworks for functionalization .
- the disclosure provides a method of generating post- reactive framework (PRF) comprising: generating a porous framework comprising a metal organic framework (MOF) , a zeolitic framework, a zeolitic imidazole framework (ZIF), a covalent organic framework (COF) or a biocompatible organic framework (BOF) , wherein a.
- PRF post- reactive framework
- the porous framework comprises a general structure M-L-M, wherein the M is transition metal and L is a linking moiety.
- the L comprises a substructure covalently linked to an alkyl or cycloalkyl group, comprising 1 to 20 carbon atoms, an aryl group comprising 1 to 5 phenyl rings, or an alkyl or aryl amine comprising alkyl or cycloalkyl groups having from 1 to 20 carbon atoms or aryl groups comprising 1 to 5 phenyl rings and a linking cluster covalently bound to the substructure.
- the linking moiety substructure is selected from any of the following:
- the post framework reactant comprises a ring structure of 1-20 carbons with functional groups comprising atoms such as N, S, O, and P.
- a metal and metal containing compounds that chelate to and add functional groups to the reactive side group is used.
- the post framework reactant undergoes reaction with the porous framework that result in the tethering of organometallic complexes to the framework.
- the post framework reactants comprises a heterocyclic compound.
- the heterocyclic compound has one or more multivalent heteroatoms, independently selected from N, 0 and S, as a part of the ring structure.
- the heterocylic compound comprises a monocyclic heterocycle.
- the monocyclic heterocycle is selected from the group consisting of: aziridine, oxirane, thiirane, azetidine, oxetane, thietane, pyrrolidine, pyrroline, imidazolidine, pyrazolidine, pyrazoline, dioxolane, sulfolane 2, 3-dihydrofuran, 2, 5-dihydrofuran tetrahydrofuran, thiophane, piperidine, 1,2,3,6- tetrahydro-pyridine, piperazine, morpholine, thiomorpholine, pyran, thiopyran, 2, 3-dihydropyran, tetrahydropyran, 1, 4-dihydropyridine, 1,4-dioxane, 1,3-dioxane, dioxane, homopiperidine, 2,3,4,
- the reaction is carried out under mild conditions with reagents that result in a modification of a reactive side group that fits with the pore size of the porous framework.
- the post reactive framework comprises a modification of the linker moiety comprising an aliphatic sulfonic acid group.
- a guest species is removed from the porous framework prior to reacting the framework with the post framework reactant.
- the disclosure also provides post reactive frameworks PRFs produced by the methods above.
- the PRFs are used in gas sorption, sensing, filtration and in catalysis.
- the disclosure provides methods to generate reactive species in porous organic frameworks and compositions derived there from.
- the methods and compositions extend to metal organic frameworks (MOFs), covalent organic frameworks (COFs), zeolitic imidazolate frameworks (ZIFs) and biocompatible organic frameworks (BOFs) .
- the porous reactive frameworks of the disclosure have unusual thermal and chemical stability and thus are ideal platforms for performing useful organic transformations under strong reaction conditions.
- the imidazolate-2-carboxaldehyde (ICA) links which join tetrahedral zinc (II) centers in a porous ZIF, were reduced by NaBH 4 to the corresponding alcohol derivative, and converted to an imine functionality in refluxing methanol. Despite these strong reaction conditions, the integrity of the structure and its crystallinity are maintained throughout the synthesis.
- the isolated ZIF derivatives indicate that those organic reactions proceeded in high conversions. In essence the success in achieving typical organic reactions in crystals of extended structures like ZIFs makes the idea of using the "crystal as a molecule" a reality and opens many opportunities for employing the arsenal of organic reactions in the covalent functionalization of extended structures.
- the disclosure provides both methods for modifying a framework after crystallization as well as compositions comprising such post-reactive frameworks.
- ZIFs -91 and -92 are exemplar of the disclosure, being MOFs that were synthesized after the framework had been crystallized. Other MOFs that fall into this category are IRMOF-3n and IRM0F-3s as well as Zr-MOF-In.
- MOFs are based on classical amine-containing structures, but are reacted with 2-methylaziridine (in the -n cases) or 1,3- propanesultone (in the -s case) .
- 2-methylaziridine in the -n cases
- 1,3- propanesultone in the -s case
- MOFs comprising a 2, 2 ' -bipyridine unit in the framework, to which can be bound a wide variety of metal ions (e.g., Pt) can be generated. All of these frameworks maintain porosity after reaction with the exception of ZIF-92, which has substantially filled pores after modification.
- Figure IA-D shows a crystal structure of ZIF-90 presented as (A) a net (line and black dot drawing), (B) a tiling to show the subdivision of space (polyhedra) in the sodalite topology, and (C) a cut away view of one of the ZIF cages with ZnN 4 tetrahedra polyhedra and the ICA links in ball-and-stick representation (C, black; N, light gray; 0, dark gray) .
- the ball represents the largest sphere to fit in the porous cage without contacting the van der Waals spheres of the framework. H atoms have been omitted for clarity.
- D a sulfonated IRMOF-3 comprising a aliphatic sulfonic acid group linked to a linking moiety of the underlying framework.
- Figure 2 shows an N 2 isotherms of ZIF-90 (top), ZIF-91
- Figure 3 shows PXRD patterns of simulated ZIF-90 (black) , ZIF-90 (bottom), ZIF-91 (middle), and ZIF-92 (top) .
- Figure 4 shows simulated PXRD pattern from ZIF-90 single crystal .
- Figure 5 shows PXRD patterns of evacuated ZIF-90 (top) , Solvent exchanged (middle) and as synthesized (bottom) .
- Figure 6 shows PXRD patterns of evacuated ZIF-91 (top) , Solvent exchanged (middle) and as synthesized (bottom) .
- Figure 1' shows PXRD patterns of evacuated ZIF-92 (top) , Solvent exchanged (middle) and as synthesized (bottom) .
- Figure 8 shows solid-state 13 C CP/MAS spectrum of ZIF-90.
- Figure 9 shows solid-state 13 C CP/MAS spectrum of ZIF-91.
- Figure 10 shows solid-state 13 C CP/MAS spectrum of ZIF-92.
- Figure 11 shows a TGA trace of as synthesized ZIF-90 after washing in methanol.
- Figure 12 shows a TGA trace of evacuated ZIF-90.
- Figure 13 shows a TGA trace of evacuated ZIF-91.
- the initial weight loss 50-150 oC is due to methanol trapped within the pores. Furthermore, the loss of weight 150-300 oC is most likely due to strongly associated solvent within the framework.
- ZIF-91 remains crystalline at 200 °C.
- Figure 14 shows a TGA trace of evacuated ZIF-92.
- the plateau (0-250 oC) TGA trace of ZIF-92 may be attributed to the imine functionality occluding the pores.
- no solvent loss is observed until approximately 250 °C as it would be trapped within the pores.
- the liberation of solvent and constant loss of weight from 250 to 500 °C most probably results from the destruction of the framework.
- ZIF-92 remains crystalline at 100 °C but losses crystallinity at 200 oC.
- Figure 15 shows an NMR spectrum for digested ZIF-90. (500
- Figure 17 shows an ESI mass spectrum of ZIF-91.
- Figure 18 shows Ar isotherms for ZIF-90 measured at 77 K.
- Connecting trace is guide for eyes.
- Figure 19 shows ZIF-90 aldehyde stretch at 1668cm "1 highlighted for clarity.
- Figure 20 shows a ZIF-92 imine stretch at 1637cm "1 highlighted for clarity.
- Figure 21 is a representative optical photographs of ZIF-90
- Figure 22 shows a PXRD pattern of ZIF-90 boiled in toluene
- Figure 23 shows PXRD pattern of ZIF-90 boiled in water 24 h.
- Figure 24 shows PXRD pattern of ZIF-90 boiled in methanol
- Figure 25 shows PXRD pattern of ZIF-90 after heating to 250 oC.
- Figure 26 shows PXRD pattern of ZIF-90 immersed in water for 18 h at room temperature.
- Figure 27 shows PXRD pattern of ZIF-91 immersed in water for 24 h at room temperature.
- Figure 28 shows PXRD pattern of ZIF-91 boiled in toluene for 18 h.
- Figure 29 shows a PXRD pattern of ZIF-91 boiled in MeOH for 18h.
- Figure 30 shows a PXRD pattern of ZIF-91 heated to 200 oC.
- Figure 31 shows a PXRD pattern of ZIF-92 heated to 100 oC.
- Figure 32 shows a PXRD pattern of ZIF-92 boiled in toluene for 18 h.
- Figure 33 shows a PXRD pattern of ZIF-92 boiled in MeOH for 18 h.
- Figure 34 shows an ORTEP drawing of asymmetric unit of ZIF- 90.
- porous metal-organic frameworks post-synthesis using, for example, mild organic reactions.
- porous reactive frameworks include metal organic frameworks (MOFs), zeolitic-imidazolate frameworks (ZIFs), covalent-organic frameworks (COFs) and biocompatible organic frameworks (BOFs) that result in materials with useful pore functionalities that cannot be accessed by traditional synthetic methods (i.e., by inclusion on the organic linker prior to framework synthesis) .
- the methods are also cheaper or more expedient than traditional synthetic methods.
- the PRFs of the disclosure are suitable for, e.g., catalysis, gas separation, gas storage, sensing, ion conduction, ion exchange membranes and drug delivery.
- Organic frameworks of the disclosure have the general structure M-L-M, wherein L is a linking moiety and M are transition metals or polydentate core.
- L is a linking moiety
- M are transition metals or polydentate core.
- the disclosure takes advantage of the modification of exposed side group on a linking moiety, post synthesis, that can be reactive and functionalized by a post-framework reactant under suitable reaction conditions.
- a "core" refers to a repeating unit or units found in a framework.
- Such a framework can comprise a homogenous repeating core or a heterogeneous repeating core structure.
- a core comprises a transition metal or cluster of transitions metals that can be linked to a linking moiety.
- a plurality of cores linked together through a linking group defines a framework.
- cluster refers to identifiable associations of 2 or more atoms. Such associations are typically established by some type of bond--ionic, covalent, Van der Waal, and the like.
- a “linking cluster” refers to a one or more reactive species capable of condensation comprising an atom capable of forming a bond between a linking moiety substructure and a metal group or core, or between a linking moiety and another linking moiety. Examples of such species are selected from the group consisting of a boron, oxygen, carbon, nitrogen, and phosphorous atom.
- the linking cluster may comprise one or more different reactive species capable of forming a link with a bridging oxygen atom.
- a linking cluster can comprise CO 2 H, CS 2 H, NO 2 , SO 3 H, Si(OH) 3 , Ge(OH) 3 , Sn(OH) 3 , Si(SH) 4 , Ge(SH) 4 , Sn(SH) 4 , PO 3 H, AsO 3 H, AsO 4 H, P(SH) 3 , As(SH) 3 , CH(RSH) 2 , C(RSH) 3 , CH(RNH 2 ) 2 , C(RNH 2 ) 3 , CH(ROH) 2 , C(ROH) 3 , CH(RCN) 2 , C(RCN) 3 , CH(SH) 2 , C(SH) 3 , CH(NH 2 ) 2 , C(NH 2 ) 3 , CH(OH) 2 , C(OH) 3 , CH(CN) 2 , and C(CN) 3 , wheuein R is an alkyl group having from 1 to 5 carbon atoms, or an aryl group comprising of
- covalent organic polyhedra refers to a non- extended covalent organic network. Polymerization in such polyhedra does not occur usually because of the presence of capping ligands that inhibit polymerization. Covalent organic polyhedra are covalent organic networks that comprise a plurality of linking clusters linking together multidentate cores such that the spatial structure of the network is a polyhedron. Typically, the polyhedra of this variation are 2 or 3 dimensional structures.
- a "linking moiety” refers to a mono-dentate or polydentate compound that bind a transition metal or a plurality of transition metals or cores, respectively.
- a linking moiety comprises a substructure covalently linked to an alkyl or cycloalkyl group, comprising 1 to 20 carbon atoms, an aryl group comprising 1 to 5 phenyl rings, or an alkyl or aryl amine comprising alkyl or cycloalkyl groups having from 1 to 20 carbon atoms or aryl groups comprising 1 to 5 phenyl rings, and in which a linking cluster (e.g., a multidentate function groups) are covalently bound to the substructure.
- a linking cluster e.g., a multidentate function groups
- a cycloalkyl or aryl substructure may comprise 1 to 5 rings that comprise either of all carbon or a mixture of carbon with nitrogen, oxygen, sulfur, boron, phosphorus, silicon and/or aluminum atoms making up the ring.
- the linking moiety will comprise a substructure having one or more carboxylic acid linking clusters covalently attached.
- the linking moiety is selected from any of the following:
- a post framework reactant refers to any organic reactant . Rings of 1-20 carbons with functional groups comprising atoms such as N, S, 0, and P are useful.
- metal and metal containing compounds that may chelate to and add functional groups or a combination of previously existing and newly added functional groups are also useful. Reactions that result in the' tethering of organometallic complexes to the framework for use as, for example, a heterogeneous catalyst can be used. For example, converting a reactive side group in a linking agent to an alcohol followed by reacting the group with an alkali earth metal to generate a metal alkoxide is provided.
- post framework reactants include, but are not limited to, heterocyclic compounds.
- the post framework reactant can be a saturated or unsaturated heterocycle.
- heterocycle used alone or as a suffix or prefix, refers to a ring-containing structure or molecule having one or more multivalent heteroatoms, independently selected from N, 0 and S, as a part of the ring structure and including at least 3 and up to about 20 atoms in the ring(s).
- Heterocycle may be saturated or unsaturated, containing one or more double bonds, and heterocycle may contain more than one ring. When a heterocycle- contains more than one ring, the rings may be fused or unfused.
- Fused rings generally refer to at least two rings share two atoms there between.
- Heterocycle may have aromatic character or may not have aromatic character.
- the term “heterocyclyl” used alone or as a suffix or prefix refers a monovalent radical derived from a heterocycle by removing one hydrogen there from.
- the term “heteroaryl” used alone or as a suffix or prefix refers to a heterocyclyl having aromatic character.
- Heterocycle includes, for example, monocyclic heterocycles such as: aziridine, oxirane, thiirane, azetidine, oxetane, thietane, pyrrolidine, pyrroline, imidazolidine, pyrazolidine, pyrazoline, dioxolane, sulfolane 2, 3-dihydrofuran, 2, 5-dihydrofuran tetrahydrofuran, thiophane, piperidine, 1,2,3,6- tetrahydro-pyridine, piperazine, morpholine, thiomorpholine, pyran, thiopyran, 2, 3-dihydropyran, tetrahydropyran, 1, 4-dihydropyridine, 1,4-dioxane, 1,3-dioxane, dioxane, homopiperidine, 2,3,4,7- tetrahydro-lH-azepine homopiperazine, 1, 3-
- heteroaryl groups for example, pyridine, pyrazine, pyrimidine, pyridazine, thiophene, furan, furazan, pyrrole, imidazole, thiazole, oxazole, pyrazole, isothiazole, isoxazole, 1,2,3- triazole, tetrazole, 1, 2, 3-thiadiazole, 1, 2, 3-oxadiazole, 1,2,4- triazole, 1, 2, 4-thiadiazole, 1, 2, 4-oxadiazole, 1, 3, 4-triazole, 1, 3, 4-thiadiazole, and 1, 3, 4-oxadiazole .
- heterocycle encompass polycyclic heterocycles, for example, indole, indoline, isoindoline, quinoline, tetrahydroquinoline, isoquinoline, tetrahydroisoquinoline, 1, 4-benzodioxan, coumarin, dihydrocoumarin, benzofuran, 2, 3-dihydrobenzofuran, isobenzofuran, chromene, chroman, isochroman, xanthene, phenoxathiin, thianthrene, indolizine, isoindole, indazole, purine, phthalazine, naphthyridine, quinoxaline, quinazoline, cinnoline, pteridine, phenanthridine, perimidine, phenanthroline, phenazine, phenothiazine, phenoxazine, 1, 2-benzisoxazole, benzothiophene, benzox
- heterocycle includes polycyclic heterocycles wherein the ring fusion between two or more rings includes more than one bond common to both rings and more than two atoms common to both rings.
- bridged heterocycles include quinuclidine, diazabicyclo [2.2.1] heptane and 7-oxabicyclo [2.2.1] heptane.
- Heterocyclyl includes, for example, monocyclic heterocyclyls, such as: aziridinyl, oxiranyl, thiiranyl, azetidinyl, oxetanyl, thietanyl, pyrrolidinyl, pyrrolinyl, imidazolidinyl, pyrazolidinyl, pyrazolinyl, dioxolanyl, sulfolanyl, 2, 3-dihydrofuranyl, 2, 5-dihydrofuranyl, tetrahydrofuranyl, thiophanyl, piperidinyl, 1, 2, 3, 6-tetrahydro-pyridinyl, piperazinyl, morpholinyl, thiomorpholinyl, pyranyl, thiopyranyl, 2,3- dihydropyranyl, tetrahydropyranyl, 1, 4-dihydropyridinyl, 1,4- dioxany
- heterocyclyl includes aromatic heterocyclyls or heteroaryl, for example, pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, thienyl, furyl, furazanyl, pyrrolyl, imidazolyl, thiazolyl, oxazolyl, pyrazolyl, isothiazolyl, isoxazolyl, 1, 2, 3-triazolyl, tetrazolyl, 1, 2, 3-thiadiazolyl, 1,2,3- oxadiazolyl, 1, 2, 4-triazolyl, 1, 2, 4-thiadiazolyl, 1,2,4- oxadiazolyl, 1, 3, 4-triazolyl, 1, 3, 4-thiadiazolyl, and 1,3,4 oxadiazolyl .
- heterocyclyl encompasses polycyclic heterocyclyls (including both aromatic or non-aromatic), for example, indolyl, indolinyl, isoindolinyl, quinolinyl, tetrahydroquinolinyl, isoquinolinyl, tetrahydroisoquinolinyl, 1,4- benzodioxanyl, coumarinyl, dihydrocoumarinyl, benzofuranyl, 2,3- dihydrobenzofuranyl, isobenzofuranyl, chromenyl, chromanyl, isochromanyl, xanthenyl, phenoxathiinyl, thianthrenyl, indolizinyl, isoindolyl, indazolyl, purinyl, phthalazinyl, naphthyridinyl, quinoxalinyl, quinazolinyl, cinnolinyl,
- heterocyclyl includes polycyclic heterocyclyls wherein the ring fusion between two or more rings includes more than one bond common to both rings and more than two atoms common to both rings.
- bridged heterocycles include quinuclidinyl, diazabicyclo [2.2.1]heptyl; and 7-oxabicyclo [2.2.1] heptyl .
- a post reactive framework agent is contacted with a ZIF, MOF, COF, or BOF framework to functionally modify the framework including pore size, binding capacity (e.g., free reactive side groups, charge etc) .
- a "zeolitic framework,” as used herein, refers to a framework of repeating cores having a zeolite-type structure.
- a zeolitic framework can comprise a structure as set forth in the Atlas of Zeolite Structure Types.
- a "zeolitic imidizolate framework” or “ZIF” refers to a zeolitic framework comprising a zeolitic structure having an imidizole, imidizolate-derivative, or imidizolate linking moiety.
- a zeolitic frameworks can comprise a network of homogenous transition metal or heterogeneous transition metals linked by a homogenous or heterogeneous linking moiety.
- the zeolitic frameworks of the disclosure can comprise any of the networks currently defined in the Atlas of Zeolite Structure Types known in the literature as well as POZ.
- the zeolitic frameworks of the disclosure provide nanoporous structure useful for filtration, gas storage and the like, as more fully described herein.
- the ZIFs can be modified post synthesis using a post reactive agent of the disclosure to change or modify the porosity or charge of the framework.
- the disclosure also provide a general synthesis of structures having zeolite framework topologies in which all tetrahedral atoms are transition metals, and the linking moieties comprise organic linkers comprising nitrogen, sulfur or oxygen organic molecules (e.g., such as imidazolate (IM) units) .
- the organic linkers may be further functionalized to modify the cage size and pore size or specificity to a guest species or gas molecule .
- Zeolitic frameworks comprise the general structure M-L- M, wherein M comprises a transition metal and L is a linking moiety.
- M comprises a transition metal
- L is a linking moiety.
- the framework comprising and M-L-M structure is selected from the group consisting of:
- A can be either C or N, wherein R 5 -R 8 are present when A 1 and A 4 comprise C, wherein R 1 , R 4 or R 9 comprise a non-sterically hindering group that does not interfere with M, wherein R 2 , R 3 , R 5 , R 8 , R 10 , R 11 , R 12 are each individually an alkyl, halo-cyano-nitro-, wherein when the linking moiety comprises structure III, R 10 , R 11 and R 12 are each individually electron withdrawing groups, and wherein one of R 6 and R 7 comprise an electron withdrawing group.
- R 1 , R 4 or R 9 comprise a non-sterically hindering electron donating group that does not interfere with M.
- R 1 , R 4 or R 9 functionalized with a group selected to interact with a particular gas or substrate.
- R 2 , R 3 , R 6 , R 7 , or R 11 are individually H or a small electron withdrawing group.
- the small electron withdrawing group is of sufficient size to increase a cage size for a ZIF of the disclosure.
- R 7 can be a chloro- group.
- the imidazolate or imidazolate derivative is selected from the group consisting of IV, V, VI, VII, VIII, and IX:
- the imidazolate or imidazolate derivative is selected from the group consisting of a substituted imidazolate; a benzimidazolate comprising a methyl-, nitro-, cyano, or chloro- group; an azabenzimidazolate; and an azabenzimidazolate wherein one or two carbon atoms on the benzimidazolate are replaced by nitrogen.
- the transition metal is selected from the group consisting of Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Y, Zr, Nb, Mo, Tc, Ru, Rh, Pd, Ag, Cd, Lu, Hf, Ta, W, Re, Os, Ir, Pt, Au, Hg, Lr, Rf, Db, Sg, Bh, Hs, Mt, Ds, Rg and Uub.
- a zeolitic framework comprises a heterogeneous combination of transition metals.
- the zeolitic framework comprises homogenous transition metal but a heterogeneous combination of linking moieties.
- a zeolitic framework comprises a heterogeneous mixture of transition metals and linking moieties.
- the linking moiety comprises a benzimidazolate (bIM) functionalized at the 5 or 4 and 5 positions to modify the pore character and/or cage structure of the framework.
- the functionalization moiety is used to increase the IM girth and comprises a small electron withdrawing group.
- the functionalization moiety can comprise, for example, a chloro-, brormo-, iodo- or fluoro-containing group.
- the disclosure provides a 5-chlorobenzimidazolate (cbIM) linked to a transition metal selected from the group consisting of Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Y, Zr, Nb, Mo, Tc, Ru, Rh, Pd, Ag, Cd, Lu, Hf, Ta, W, Re, Os, Ir, Pt, Au, Hg, Lr, Rf, Db, Sg, Bh, Hs, Mt, Ds, Rg and ⁇ ub .
- the cbIM linking moiety is linked to a Zn or Co transition metal.
- the imidazolate or imadazolate derivative linking moiety has a structure selected from the group consisting of:
- the linking moiety of the disclosure can comprise substituted or unsubstituted aromatic rings, substituted or unsubstituted heteroaromatic rings, substituted or unsubstituted nonaromatic rings, substituted or unsubstituted nonaromatic heterocyclic rings, or saturated or unsaturated, substituted or unsubstituted, hydrocarbon groups.
- the saturated or unsaturated hydrocarbon groups may include one or more heteroatoms .
- the linking moiety substructure can comprise Formula XI:
- R 1 , R 2 , R 3 , and R 4 are each independently H, alkyl, aryl, OH, alkoxy, alkenes, alkynes, phenyl and substitutions of the foregoing, sulfur-containing groups (e.g., thioalkoxy) , silicon- containing groups, nitrogen-containing groups (e.g., amides), oxygen-containing groups (e.g., ketones, and aldehydes), halogen, nitro, amino, cyano, boron-containing groups, phosphorus-containing groups, carboxylic acids, or esters.
- sulfur-containing groups e.g., thioalkoxy
- silicon-containing groups e.g., silicon-containing groups
- nitrogen-containing groups e.g., amides
- oxygen-containing groups e.g., ketones, and aldehydes
- halogen nitro, amino, cyano, boron-containing groups, phosphorus-containing groups, carboxylic acids
- the linking group comprises a structure selected from the group consisting of:
- Ri, R2, R 3 , R4/ R 5 , and Re are each independently H, alkyl, aryl, OH, alkoxy, alkenes, alkynes, phenyl and substitutions of the foregoing, sulfur-containing groups (e.g., thioalkoxy) , silicon- containing groups, nitrogen-containing groups (e.g., amides), oxygen-containing groups (e.g., ketones, and aldehydes), halogen, nitro, amino, cyano, boron-containing groups, phosphorus-containing groups, carboxylic acids, or esters.
- Ri, R2, R3, R4 are each independently selected from the group consisting of NH 2 ,
- linking moiety is described by
- R ⁇ 6 are each independently H, alkyl, aryl, OH, alkoxy, alkenes, alkynes, phenyl and substitutions of the foregoing, sulfur- containing groups (e.g., thioalkoxy) , silicon-containing groups, nitrogen-containing groups (e.g., amides), oxygen-containing groups (e.g., ketones, and aldehydes), halogen, nitro, amino, cyano, boron-containing groups, phosphorus-containing groups, carboxylic acids, or esters and T is a tetrahedral atom (e.g., carbon, silicon, germanium, tin) or a tetrahedral group or cluster.
- linking moiety is described by
- R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R ⁇ , R9, Rio/ Rn, and R i2 are each independently H, alkyl, aryl, OH, alkoxy, alkenes, alkynes, phenyl and substitutions of the foregoing, sulfur-containing groups (e.g., thioalkoxy), silicon-containing groups, nitrogen-containing groups (e.g., amides), oxygen-containing groups (e.g., ketones, and aldehydes), halogen, nitro, amino, cyano, boron-containing groups, phosphorus-containing groups, carboxylic acids, or esters.
- Ri, R 2 , R 3 , R 4 are each independently selected from the group consisting of
- R and R 12 are each independently H, alkyl, aryl, OH, alkoxy, alkenes, alkynes, phenyl and substitutions of the foregoing, sulfur-containing groups (e.g., thioalkoxy) , silicon-containing groups, nitrogen-containing groups (e.g., amides), oxygen-containing groups (e.g., ketones, and aldehydes), halogen, nitro, amino, cyano, boron-containing groups, phosphorus-containing groups, carboxylic acids, or esters.
- Ri, R 2 , R 3 , R 4 are each independently selected from the group consisting of
- R 1 through R 12 are each independently H, alkyl, aryl, OH, alkoxy, alkenes, alkynes, phenyl and substitutions of the foregoing, sulfur-containing groups (e.g., thioalkoxy) , silicon- containing groups, nitrogen-containing groups (e.g., amides), oxygen-containing groups (e.g., ketones, and aldehydes), halogen, nitro, amino, cyano, boron-containing groups, phosphorus-containing groups, carboxylic acids, or esters; and n is an integer greater than or equal to 1.
- a framework can undergo post synthetic modification by reacting the framework with a reactive specie.
- R 2 of Formula XI is NH 2 reaction with an aziridine containing compound results in opening of the reactive species ring depicted generally by:
- PRFs post synthesis functionalized frameworks
- PRFs comprise the general structure M-L-M wherein the transition metals or cores are linked by a linking moiety that comprises a side group useful for post synthesis modification .
- the PRFs can comprise any of the types assigned by X-ray analysis to the ABW, AGO, AEI, AEL, AEN, AET, AFG, AFI, AFN, AFO, AFR, AFS, AFT, AFX, AFY, AHT, ANA, APC, APD, AST, ATN, ATO, ATS, ATT, ATV, AWO, AWW, BEA, BIK, BOG, BPH, BRE, CAN, CAS, CFI, CGF, CGS, CHA, CHI, CLO, CON, CZP, DAC, DDR, DFO, DFT, DOH, DON, EAB, EDI, EMT, EPI, ERI, ESV, EUO, FAU, FER, GIS, GME, GOO, HEU, IFR, ISV, ITE, JBW, KFI, LAU, LEV, LIO, LOS, LOV, LTA, LTL, LTN, MAZ
- Useful transition metal comprise any one or more of the following: Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Y, Zr, Nb, Mo, Tc, Ru, Rh, Pd, Ag, Cd, Lu, Hf, Ta, W, Re, Os, Ir, Pt, Au, Hg, Lr, Rf, Db, Sg, Bh, Hs, Mt, Ds, Rg, and Uub.
- the transition metal is Zn or Co.
- the framework e.g., a PRF
- ZIFs having any of the following framework codes can be Obtained: ABW, ACO, AEI, AEL, AEN, AET, AFG, AFI, AFN, AFO, AFR, AFS, AFT, AFX, AFY, AHT, ANA, APC, APD, AST, ASV, ATN, ATO, ATS, ATT, ATV, AWO, AWW, BCT, BEA, BEC, BIK, BOG, BPH, BRE, CAN, CAS, CDO, CFI, CGF, CGS, CHA, CHI, CLO, CON, CZP, DAC, DDR, DFO, DFT, DOH, DON, EAB, EDI, EMT, EON, EPI, ERI, ESV, ETR, EUO, EZT, FAR, FAU, FER,
- a framework of the disclosure such as a ZIF
- a ZIF can be synthesized by using solvothermal methods. Highly crystalline materials are obtained by combining the requisite hydrated metal salt (e.g., nitrate) and, for example, an imidazole-type linker in an amide solvent such as N,N-diethylformamide (DEF) . The resulting solutions are heated (85-15OoC) and zeolitic frameworks of the disclosure are precipitated after 48-96 h and were readily isolated.
- amide solvent such as N,N-diethylformamide (DEF)
- the disclosure also provides covalently linked organic frameworks (COFs) .
- COFs covalently linked organic frameworks
- each linking moiety is linked to at least one, typically two, distinct linking moieties.
- these COFs are crystalline materials that may be either polycrystalline or even single crystals.
- the linking moiety may be the same throughout the net (i.e., a homogenous net) or may be different or alternating types of multidentate cores (i.e., a heterogeneous net; in this aspect the denticity refers to the number of neighboring cores to which a particular core is bound) .
- the disclosure provides a covalent organic framework comprising two or more organic linking moieties covalently bonded to a linking cluster, the linking cluster comprising an identifiable association of 2 or more atoms, wherein the covalent bonds between each linking moiety and the linking cluster take place between atoms selected from carbon, boron, oxygen, nitrogen and phosphorus and at least one of the atoms in each covalent bond between a linking moiety and the linking cluster is oxygen.
- One or more COFs can be covalently bonded to one another each COF can be identical or different in structure.
- the covalently linked organic frameworks or polyhedra of the disclosure optionally further comprise a guest species.
- a guest species may increase the surface area of the covalently linked organic networks.
- the covalentlV linked organic networks of the disclosure further comprise an adsorbed chemical species.
- adsorbed chemical species include for example, ammonia, carbon dioxide, carbon monoxide, hydrogen, amines, methane, oxygen, argon, nitrogen, organic dyes, polycyclic organic molecules, metal ions, inorganic clusters, organometallic clusters, and combinations thereof.
- the linking moiety further comprises a side group selected from the group consisting of
- X I, 2, or 3 in addition to the linking cluster.
- Such side groups are useful for post-synthetic modification of the COF framework using reactive species such as a heterocycle as described above .
- a method for forming a covalently linked organic frameworks and polyhedra set forth above utilizes a linking moiety comprising at least one boron-containing cluster for use in condensation into an extended crystalline materials.
- a linking moiety comprises a boron-containing cluster that self-condenses with other linking moieties.
- a first linking moiety comprising a boron-containing cluster is condensed with a linking moiety lacking a boron-containing cluster.
- the crystalline product may be either polycrystalline or single crystal.
- the condensation forms a porous, semicrystalline to crystalline organic materials with high surface areas.
- Scheme 2 provides an example of the reaction of BDBA with TBST to form a 3-connected sheet.
- the aromatic rings of both the starting materials and products of Scheme 2 are optionally substituted with alkyl, OH, alkoxy, sulfur-containing groups (e.g., thi'oalkoxy) , silicon- containing groups, halogen, nitro, amino, cyano, boron-containing groups, phosphorus-containing groups, carboxylic acids, or esters.
- the COFs of the disclosure can take any framework/structure.
- COFs having any of the following framework type codes can be obtained: ABW ACO AEI AEL AEN AET AFG AFI AFN AFO AFR AFS AFT AFX AFY AHT ANA APC APD AST ASV ATN ATO ATS ATT ATV AWO AWW BCT *BEA BEC BIK BOG BPH BRE CAN CAS CDO CFI CGF CGS CHA CHI CLO CON CZP DAC DDR DFO DFT DOH DON EAB EDI EMT EON EPI ERI ESV ETR EUO EZT FAR FAU FER FRA GIS GIU GME GON GOO HEU IFR IHW ISV ITE ITH ITW IWR IWV IWW JBW KFI LAU LEV LIO LIT LOS LOV LTA LTL LTN MAR MAZ MEI MEL MEP MER MFI MFS MON MOR MOZ MSE MSO MTF MTN MTT MT
- a framework on the disclosure may be interpenetrating.
- a framework comprises an adsorbed chemical species (e.g., ammonia, carbon dioxide, carbon monoxide, hydrogen, amines, methane, oxygen, argon, nitrogen, argon, organic dyes, polycyclic organic molecules, and combinations thereof) the species may be exchanged or removed prior to reaction with a post framework reactant of the disclosure.
- the resulting functionalized frameworks e.g., PRFs
- PRFs provide useful sensors, absorbent materials, drug delivery devices and the like.
- the device includes a sorbent comprising a PRF provided herein or obtained by the methods of the disclosure.
- the uptake can be reversible or non-reversible.
- the sorbent is included in discrete sorptive particles.
- the sorptive particles may be embedded into or fixed to a solid liquid- and/or gas-permeable three-dimensional support.
- the sorptive particles have pores for the reversible uptake or storage of liquids or gases and wherein the sorptive particles can reversibly adsorb or absorb the liquid or gas.
- a device provided herein comprises a storage unit for the storage of chemical species such as ammonia, carbon dioxide, carbon monoxide, hydrogen, amines, methane, oxygen, argon, nitrogen, argon, organic dyes, polycyclic organic molecules, and combinations thereof.
- chemical species such as ammonia, carbon dioxide, carbon monoxide, hydrogen, amines, methane, oxygen, argon, nitrogen, argon, organic dyes, polycyclic organic molecules, and combinations thereof.
- the method includes contacting the chemical species with a sorbent that comprises a PRF provided herein.
- the uptake of the chemical species may include storage of the chemical species.
- the chemical species is stored under conditions suitable for use as an energy source.
- Also provided are methods for the sorptive uptake of a chemical species which includes contacting the chemical species with a device provided described herein.
- Natural gas is an important fuel gas and it is used extensively as a basic raw material in the petrochemical and other chemical process industries.
- the composition of natural gas varies widely from field to field.
- Many natural gas reservoirs contain relatively low percentages of hydrocarbons (less than 40%, for example) and high percentages of acid gases, principally carbon dioxide, but also hydrogen sulfide, carbonyl sulfide, carbon disulfide and various mercaptans.
- Removal of acid gases from natural gas produced in remote locations is desirable to provide conditioned or sweet, dry natural gas either for delivery to a pipeline, natural gas liquids recovery, helium recovery, conversion to liquefied natural gas (LNG) , or for subsequent nitrogen rejection.
- LNG liquefied natural gas
- CO 2 is corrosive in the presence of water, and it can form dry ice, hydrates and can cause freeze-up problems in pipelines and in cryogenic equipment often used in processing natural gas. Also, by not contributing to the heating value, CO 2 merely adds to the cost of gas transmission.
- Natural gas is typically treated in high volumes, making even slight differences in capital and operating costs of the treating unit significant factors in the selection of process technology. Some natural gas resources are now uneconomical to produce because of processing costs. There is a continuing need for improved natural gas treating processes that have high reliability and represent simplicity of operation.
- ZIFs zeolitic imidazolate frameworks
- other frameworks which have unusual thermal and chemical stability, and thus are ideal platforms for performing useful organic transformations under strong reaction conditions.
- Methods of generating porous ZIFs, COFs, MOFs and BOFs are described herein.
- solvent guest species in the as-synthesized ZIFs, COFs, MOFs and BOFs are removed by immersing the crystals in a polar solvent such as methanol, related alkanols (e.g., ethanol and butanol) and related compounds such as chloromethane and methoxymethane .
- a polar solvent such as methanol, related alkanols (e.g., ethanol and butanol) and related compounds such as chloromethane and methoxymethane .
- the solvent is then evacuated.
- the links in the framework e.g., the imidazolate-2-carboxaldehyde (ICA) links, which join tetrahedral zinc(II) centers in a ZIF
- ICA imidazolate-2-carboxaldehyde
- the isolated ZIF derivatives indicate that those organic reactions proceeded in high conversions. In essence the success in achieving typical organic reactions in crystals of extended structures like ZIFs makes the idea of using the "crystal as a molecule" a reality and opens many opportunities for employing the arsenal of organic reactions in the covalent functionalization of extended structures.
- a new crystalline ZIF structure (termed ZIF-90, Figure 1) was synthesized by heating a solution mixture of H-ICA and Zn(NO 3 ) 2 ⁇ 4H 2 O (3:2 mol ratio) in N, N-dimethylformamide (DMF) at 100 °C for 18 h.
- DMF N, N-dimethylformamide
- the same material can also be obtained by diffusion of a triethylamine and hexane solution into a DMF mixture of H-ICA and Zn (NO 3 ) 2 ⁇ 4H 2 O at 25 °C for 24 h.
- the 13 C CP/MAS NMR spectrum showed the expected resonances at 129, 150, and 178 ppm for the symmetrically equivalent 4- and 5-carbon atoms of the imidazolate, the 2-carbon atom of the imidazolate and the aldehyde carbon atom, respectively.
- a strong band at 1678 cm-1 (vCdO) observed in the FTIR spectrum provided further evidence for the presence of aldehyde in bulk ZIF- 90 samples.
- ZIF-91 Given the permanent porosity of ZIF-90 and its exceptional chemical stability, useful organic transformations were performed on its evacuated crystalline samples. Specifically, reduction of aldehyde to alcohol functionality was successfully achieved by reacting ZIF-90 with NaBH 4 in methanol at 60 oC for 24 h to give ZIF-91 (Scheme IIIB) . Remarkably, ZIF-91 maintained the high crystallinity of the parent framework (ZIF-90) as confirmed by their coincident PXRD patterns ( Figure 3) . The presence of the alcohol group in ZIF-91 bulk samples was revealed by 13 C CP/MAS NMR spectroscopy.
- the FTIR spectrum of ZIF-92 was devoid of the vCdO stretching frequency at 1678 cm “1 and showed the appearance of a peak at 1637 cm “1 due to the vCdN bond of the imine.
- the high crystallinity of the ZIF structure was maintained as evidenced by the PXRD pattern of ZIF-92 ( Figure 3) .
- the presence of the imine functionality in ZIF-92 severely constricts the pore aperture and prevents N2 molecules from accessing the interior of the pores, as confirmed by its gas adsorption isotherm behavior ( Figure 2) .
- Zinc nitrate tetrahydrate (Zn(NO 3 J 2 -4H 2 O) (0.13 g, 0.50 mmol) and imidazole-2-carboxaldehyde (0.07 g, 0.75 mmol) in DMF (10 mL) was placed in a desiccator under an atmosphere of triethylamine (5 mL) in hexane (200 mL) .
- the reaction was allowed to sit at room temperature for 24 h.
- the crystalline powder obtained was filtered and washed with methanol (3 ⁇ 5 mL) .
- Procedure for covalent post synthetic modification of ZIF-91 and ZIF-92 are as follows. Dried ZIF-90 crystals (0.10 g, 0.39 mmol) were suspended in methanol (10 mL) and NaBH4 (0.06 g, 1.56 mmol), and refluxed for 24 h. The reaction mixture was filtered and the solid was washed 2-3 times with fresh methanol (20 mL) . The microcrystalline solid was further exchanged with fresh methanol (20 mL) for 24 h. The solid was dried under vacuum (10 ⁇ 2 Torr) for 24 h at room temperature. Yield (0.09 g, 89%), conversion 77 %. It is worth noting that higher conversion of ZIF-90 to ZIF-91 may be achieved through reaction times exceeding 24 h, however, a reduction in crystallinity is observed.
- Powder X-ray data were collected using a Bruker D8-Discover ⁇ -2 ⁇ diffractometer in reflectance Bragg-Brentano geometry employing Ni filtered Cu Ka line focused radiation at 1600 W (40 kV, 40 mA) power and equipped with a Vantec Line detector. Radiation was focused using parallel focusing Gobel mirrors. The system was also outfitted with an anti- scattering shield that prevents incident diffuse radiation from hitting the detector, preventing the normally large background at 2 ⁇ ⁇ 3. Samples were mounted on zero background sample holders by dropping powders from a wide-blade spatula and then leveling the sample with a razor blade.
- Solid state 13C CP/MAS nuclear magnetic resonance spectroscopy High resolution solid-state nuclear magnetic resonance (NMR) spectra were recorded at ambient pressure on a Bruker DSX-300 spectrometer using a standard Bruker magic angle- spinning (MAS) probe with 4 mm (outside diameter) zirconia rotors. The magic angle was adjusted by maximizing the number and amplitudes of the signals of the rotational echoes observed in the 79Br MAS FID signal from KBr.
- Cross-polarization with MAS (CP/MAS) was used to acquire 13C data at 75.47 MHz.
- the 1 H and 13 C ninety- degree pulse widths were both 4 ms .
- the CP contact time varied from 1.5 to 5 ms.
- High power two-pulse phase modulation (TPPM) IH decoupling was applied during data acquisition.
- the decoupling frequency corresponded to 72 kHz.
- the MAS sample-spinning rate was 10 kHz.
- Recycle delays between scans varied between 3 and 10 s, depending upon the compound as determined by observing no apparent loss in the 13 C signal from one scan to the next.
- the 13C chemical shifts are given relative to tetramethylsilane as zero ppm, calibrated using the methylene carbon signal of adamantane assigned to 37.77 ppm as secondary reference.
- a liquid nitrogen sample bath (77 K) was used for N 2 , Ar, and H 2 isotherm measurements.
- the N 2 , Ar, H 2 and He gases used were UHP grade.
- the Langmuir or BET method was applied using the adsorption branches of the N 2 isotherms assuming a N 2 cross- sectional area of 16.2 A2/molecule.
- the total pore volumes (Vp) were determined using the Dubinin-Raduskavich (DR) method. Table Sl. Summary ofthe porosity ofZiFs
- IR Infrared Spectroscopy
- FT-IR spectra of ZIF-90 and ZIF-92 were obtained as KBr pellets using Nicolet 400 Impact spectrometer, signals are given in wavenumbers (cm "1 ) .
- General Data Collection and Refinement Procedures: Data were collected on a Bruker SMART APEXII three circle diffractometer equipped with a CCD area detector and operated at 1200 W power (40 kV, 30 mA) to generate Cu Ka radiation ( ⁇ 1.5418 A) .
- the incident X-ray beam was focused and monochromated using Bruker Excalibur Gobel mirror optics.
- a crystal of ZIF-90 was mounted on a nylon CryoLoops (Hampton Research) with Paraton-N (Hampton Research) .
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
This disclosure relates to porous frameworks for gas separation, sensing and drug/biomolecule delivery. More particularly, the disclosure relates to reactive porous frameworks for functionalization.
Description
POROUS REACTIVE FRAMEWORKS
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority under 35 U. S. C. §119 to U.S. Provisional Application Serial No. 61/138,732, filed December 18, 2008, the disclosure of which is incorporated herein by reference in its entirety.
STATEMENT REGARDING FEDERALLY SPONOSRED RESEARCH [0002] The invention was made with Government support of Grant No. W911NF-06-1-0405 awarded by the United States Army, Joint Science and Technology Office. The government has certain rights in the invention.
FIELD OF THE INVENTION
[0003] This disclosure relates to porous frameworks for gas separation, sensing and drug/biomolecule delivery. More particularly, the disclosure relates to reactive porous frameworks for functionalization .
BACKGROUND
[0004] The ability to functionalize molecules is a long standing practice in organic chemistry that has led to advances in the synthesis of natural products, pharmaceuticals, and polymers. However, the analogous chemistry of crystalline extended solids remains undeveloped because they generally lose their structural integrity under the reaction conditions required to carry out meaningful organic transformations.
SUMMARY
[0005] The disclosure provides a method of generating post- reactive framework (PRF) comprising: generating a porous framework comprising a metal organic framework (MOF) , a zeolitic framework, a zeolitic imidazole framework (ZIF), a covalent organic framework (COF) or a biocompatible organic framework (BOF) , wherein a. linking moiety of the porous framework comprises one or more reactive side groups selected from the group consisting of -NH2, -CN, -OH, =0, =S, -SH, -P, -Br, -CL, -I, -F,
wherein X=I, 2, or 3; and reacting the framework with a post framework reactant comprising an organic species under conditions wherein the post framework reactant modifies the reactive side group to form a PRF. In one embodiment, the porous framework comprises a general structure M-L-M, wherein the M is transition metal and L is a linking moiety. In another embodiment, the L comprises a substructure covalently linked to an alkyl or cycloalkyl group, comprising 1 to 20 carbon atoms, an aryl group comprising 1 to 5 phenyl rings, or an alkyl or aryl amine comprising alkyl or cycloalkyl groups having from 1 to 20 carbon atoms or aryl groups comprising 1 to 5 phenyl rings and a linking cluster covalently bound to the substructure. In yet another embodiment, the linking moiety substructure is selected from any of the following:
wherein R1, R2, R3, R4 are each individually selected from the group consisting of -NH2, -CN, -OH, =0, =S, -SH, -P, -Br, -Cl, -I, -F,
wherein X=1, 2, or 3. In yet another embodiment, the post framework reactant comprises a ring structure of 1-20 carbons with functional groups comprising atoms such as N, S, O, and P. In one embodiment, a metal and metal containing compounds that chelate to and add functional groups to the reactive side group is used. In another embodiment, the post framework reactant undergoes reaction with the porous framework that result in the tethering of organometallic complexes to the framework. In yet another
embodiment, the post framework reactants comprises a heterocyclic compound. In one embodiment, the heterocyclic compound has one or more multivalent heteroatoms, independently selected from N, 0 and S, as a part of the ring structure. In yet another embodiment, the heterocylic compound comprises a monocyclic heterocycle. In yet a further embodiment, the monocyclic heterocycle is selected from the group consisting of: aziridine, oxirane, thiirane, azetidine, oxetane, thietane, pyrrolidine, pyrroline, imidazolidine, pyrazolidine, pyrazoline, dioxolane, sulfolane 2, 3-dihydrofuran, 2, 5-dihydrofuran tetrahydrofuran, thiophane, piperidine, 1,2,3,6- tetrahydro-pyridine, piperazine, morpholine, thiomorpholine, pyran, thiopyran, 2, 3-dihydropyran, tetrahydropyran, 1, 4-dihydropyridine, 1,4-dioxane, 1,3-dioxane, dioxane, homopiperidine, 2,3,4,7- tetrahydro-lH-azepine homopiperazine, 1, 3-dioxepane, 4,7-dihydro- 1, 3-dioxepin, and hexamethylene oxide. In yet an even further embodiment, the heterocycle is selected from the group consisting of:
In one embodiment, the reaction is carried out under mild conditions with reagents that result in a modification of a reactive side group that fits with the pore size of the porous framework. In one embodiment, the post reactive framework comprises a modification of the linker moiety comprising an aliphatic sulfonic acid group. In some embodiments, a guest species is removed from the porous framework prior to reacting the framework with the post framework reactant.
[0006] The disclosure also provides post reactive frameworks PRFs produced by the methods above. In yet another embodiment, the PRFs are used in gas sorption, sensing, filtration and in catalysis. [0007] The disclosure also provides a porous framework comprising a plurality of multidentate cores linked to one another by a linking moiety, the linking moiety comprising a side group selected from the group consisting of NH2, CN, OH, =0, =S, SH, P, Br, CL, I, F,
wherein X=I, 2, or 3 in addition to a linking cluster. [0008] The disclosure provides methods to generate reactive species in porous organic frameworks and compositions derived there from. The methods and compositions extend to metal organic frameworks (MOFs), covalent organic frameworks (COFs), zeolitic imidazolate frameworks (ZIFs) and biocompatible organic frameworks (BOFs) . The porous reactive frameworks of the disclosure have unusual thermal and chemical stability and thus are ideal platforms for performing useful organic transformations under strong reaction conditions. For example, the imidazolate-2-carboxaldehyde (ICA) links, which join tetrahedral zinc (II) centers in a porous ZIF, were reduced by NaBH4 to the corresponding alcohol derivative, and converted to an imine functionality in refluxing methanol. Despite these strong reaction conditions, the integrity of the structure and its crystallinity are maintained throughout the synthesis. The isolated ZIF derivatives indicate that those organic reactions proceeded in high conversions. In essence the success in achieving typical organic reactions in crystals of extended structures like ZIFs makes the idea of using the "crystal as a molecule" a reality and opens many opportunities for employing the arsenal of organic reactions in the covalent functionalization of extended structures. [0009] The disclosure provides both methods for modifying a framework after crystallization as well as compositions comprising such post-reactive frameworks. ZIFs -91 and -92 are exemplar of the disclosure, being MOFs that were synthesized after the framework had been crystallized. Other MOFs that fall into this category are IRMOF-3n and IRM0F-3s as well as Zr-MOF-In. These MOFs are based on classical amine-containing structures, but are reacted with 2-methylaziridine (in the -n cases) or 1,3-
propanesultone (in the -s case) . Using such methods of post crystallization one can generate a multitude of frameworks having tuned pores. In one embodiment, MOFs comprising a 2, 2 ' -bipyridine unit in the framework, to which can be bound a wide variety of metal ions (e.g., Pt) can be generated. All of these frameworks maintain porosity after reaction with the exception of ZIF-92, which has substantially filled pores after modification. BRIEF DESCRIPTION OF THE DRAWINGS
[0010] Figure IA-D shows a crystal structure of ZIF-90 presented as (A) a net (line and black dot drawing), (B) a tiling to show the subdivision of space (polyhedra) in the sodalite topology, and (C) a cut away view of one of the ZIF cages with ZnN4 tetrahedra polyhedra and the ICA links in ball-and-stick representation (C, black; N, light gray; 0, dark gray) . The ball represents the largest sphere to fit in the porous cage without contacting the van der Waals spheres of the framework. H atoms have been omitted for clarity. (D) a sulfonated IRMOF-3 comprising a aliphatic sulfonic acid group linked to a linking moiety of the underlying framework.
[0011] Figure 2 shows an N2 isotherms of ZIF-90 (top), ZIF-91
(middle), and ZIF-92 (bottom) measured at 77 K. ZIF-90, 91, and 92 pore apertures are shown as space filled representations.
[0012] Figure 3 shows PXRD patterns of simulated ZIF-90 (black) , ZIF-90 (bottom), ZIF-91 (middle), and ZIF-92 (top) .
[0013] Figure 4 shows simulated PXRD pattern from ZIF-90 single crystal .
[0014] Figure 5 shows PXRD patterns of evacuated ZIF-90 (top) , Solvent exchanged (middle) and as synthesized (bottom) .
[0015] Figure 6 shows PXRD patterns of evacuated ZIF-91 (top) , Solvent exchanged (middle) and as synthesized (bottom) .
[0016] Figure 1' shows PXRD patterns of evacuated ZIF-92 (top) , Solvent exchanged (middle) and as synthesized (bottom) .
[0017] Figure 8 shows solid-state 13C CP/MAS spectrum of ZIF-90.
[0018] Figure 9 shows solid-state 13C CP/MAS spectrum of ZIF-91.
[0019] Figure 10 shows solid-state 13C CP/MAS spectrum of ZIF-92.
[0020] Figure 11 shows a TGA trace of as synthesized ZIF-90 after washing in methanol.
[0021] Figure 12 shows a TGA trace of evacuated ZIF-90.
[0022] Figure 13 shows a TGA trace of evacuated ZIF-91. The initial weight loss 50-150 ºC is due to methanol trapped within the pores. Furthermore, the loss of weight 150-300 ºC is most likely due to strongly associated solvent within the framework. ZIF-91 remains crystalline at 200 °C.
[0023] Figure 14 shows a TGA trace of evacuated ZIF-92. The plateau (0-250 ºC) TGA trace of ZIF-92 may be attributed to the imine functionality occluding the pores. Thus no solvent loss is observed until approximately 250 °C as it would be trapped within the pores. The liberation of solvent and constant loss of weight from 250 to 500 °C most probably results from the destruction of the framework. ZIF-92 remains crystalline at 100 °C but losses crystallinity at 200 ºC.
[0024] Figure 15 shows an NMR spectrum for digested ZIF-90. (500
MHz, 20% DC1/D2O) δH 7.2 ppm (2H, s, CH-imidazole ring), (IH, s,
CCHO) , 4.79 ppm (D2O) .
[0025] Figure 16. NMR spectrum for digested ZIF-91. (500 MHz, 20%
DC1/D2O) δH 7.31 ppm (2H, s, CH-imidazole ring aldehyde), 7.27 ppm
(2H, s, CH-imidazole ring alcohol) (IH, s, CCHO), 4.79 ppm (D2O).
[0026] Figure 17 shows an ESI mass spectrum of ZIF-91.
[0027] Figure 18 shows Ar isotherms for ZIF-90 measured at 77 K.
No step with a significant hysteresis was observed, which indicates that ZIF-90 does not have a mesopore. Filled and open circles represent adsorption and desorption branch, respectively.
Connecting trace is guide for eyes.
[0028] Figure 19 shows ZIF-90 aldehyde stretch at 1668cm"1 highlighted for clarity.
[0029] Figure 20 shows a ZIF-92 imine stretch at 1637cm"1 highlighted for clarity.
[0030] Figure 21 is a representative optical photographs of ZIF-90
(0.1 mm) found in vials after solvothermal process.
[0031] Figure 22 shows a PXRD pattern of ZIF-90 boiled in toluene
24 h.
[0032] Figure 23 shows PXRD pattern of ZIF-90 boiled in water 24 h.
[0033] Figure 24 shows PXRD pattern of ZIF-90 boiled in methanol
24 h.
[0034] Figure 25 shows PXRD pattern of ZIF-90 after heating to 250 ºC.
[0035] Figure 26 shows PXRD pattern of ZIF-90 immersed in water for 18 h at room temperature.
[0036] Figure 27 shows PXRD pattern of ZIF-91 immersed in water for 24 h at room temperature.
[0037] Figure 28 shows PXRD pattern of ZIF-91 boiled in toluene for 18 h.
[0038] Figure 29 shows a PXRD pattern of ZIF-91 boiled in MeOH for 18h.
[0039] Figure 30 shows a PXRD pattern of ZIF-91 heated to 200 ºC. [0040] Figure 31 shows a PXRD pattern of ZIF-92 heated to 100 ºC. [0041] Figure 32 shows a PXRD pattern of ZIF-92 boiled in toluene for 18 h.
[0042] Figure 33 shows a PXRD pattern of ZIF-92 boiled in MeOH for 18 h.
[0043] Figure 34 shows an ORTEP drawing of asymmetric unit of ZIF- 90.
DETAILED DESCRIPTION
[0044] As used herein and in the appended claims, the singular forms "a," "and," and "the" include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to "a species" includes a plurality of such species and reference to "the framework" includes reference to one or more frameworks and equivalents thereof, and so forth.
[0045] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood to one of ordinary skill in the art to which this disclosure belongs. Although any methods and reagents similar or equivalent to those described herein can be used in the practice of the disclosed methods and compositions, the exemplary methods and materials are now described.
[0046] Also, the use of "or" means "and/or" unless stated otherwise. Similarly, "comprise," "comprises," "comprising" "include," "includes," and "including" are interchangeable and not intended to be limiting.
[0047] It is to be further understood that where descriptions of various embodiments use the term "comprising, " those skilled in the art would understand that in some specific instances, an embodiment can be alternatively described using language "consisting essentially of" or "consisting of." [0048] All publications mentioned herein are incorporated herein by reference in full for the purpose of describing and disclosing the methodologies, which are described in the publications, which might be used in connection with the description herein. The publications discussed above and throughout the text are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the inventors are not entitled to antedate such disclosure by virtue of prior disclosure. [0049] The disclosure demonstrates the functionalizing of organic links of porous metal-organic frameworks post-synthesis using, for example, mild organic reactions. Such porous reactive frameworks (PRFs) include metal organic frameworks (MOFs), zeolitic-imidazolate frameworks (ZIFs), covalent-organic frameworks (COFs) and biocompatible organic frameworks (BOFs) that result in materials with useful pore functionalities that cannot be accessed by traditional synthetic methods (i.e., by inclusion on the organic linker prior to framework synthesis) . The methods are also cheaper or more expedient than traditional synthetic methods. The PRFs of the disclosure are suitable for, e.g., catalysis, gas separation, gas storage, sensing, ion conduction, ion exchange membranes and drug delivery. Organic frameworks of the disclosure have the general structure M-L-M, wherein L is a linking moiety and M are transition metals or polydentate core. The disclosure takes advantage of the modification of exposed side group on a linking moiety, post synthesis, that can be reactive and functionalized by a post-framework reactant under suitable reaction conditions. [0050] As used herein, a "core" refers to a repeating unit or units found in a framework. Such a framework can comprise a homogenous repeating core or a heterogeneous repeating core structure. A core comprises a transition metal or cluster of transitions metals that can be linked to a linking moiety. A
plurality of cores linked together through a linking group defines a framework.
[0051] The term "cluster" refers to identifiable associations of 2 or more atoms. Such associations are typically established by some type of bond--ionic, covalent, Van der Waal, and the like. [0052] A "linking cluster" refers to a one or more reactive species capable of condensation comprising an atom capable of forming a bond between a linking moiety substructure and a metal group or core, or between a linking moiety and another linking moiety. Examples of such species are selected from the group consisting of a boron, oxygen, carbon, nitrogen, and phosphorous atom. In some embodiments, the linking cluster may comprise one or more different reactive species capable of forming a link with a bridging oxygen atom. For example, a linking cluster can comprise CO2H, CS2H, NO2, SO3H, Si(OH)3, Ge(OH)3, Sn(OH)3, Si(SH)4, Ge(SH)4, Sn(SH)4, PO3H, AsO3H, AsO4H, P(SH)3, As(SH)3, CH(RSH)2, C(RSH)3, CH(RNH2)2, C(RNH2)3, CH(ROH)2, C(ROH)3, CH(RCN)2, C(RCN)3, CH(SH)2, C(SH)3, CH(NH2)2, C(NH2)3, CH(OH)2, C(OH)3, CH(CN)2, and C(CN)3, wheuein R is an alkyl group having from 1 to 5 carbon atoms, or an aryl group comprising 1 to 2 pheny rings.
[0053] The term "covalent organic polyhedra" refers to a non- extended covalent organic network. Polymerization in such polyhedra does not occur usually because of the presence of capping ligands that inhibit polymerization. Covalent organic polyhedra are covalent organic networks that comprise a plurality of linking clusters linking together multidentate cores such that the spatial structure of the network is a polyhedron. Typically, the polyhedra of this variation are 2 or 3 dimensional structures. [0054] A "linking moiety" refers to a mono-dentate or polydentate compound that bind a transition metal or a plurality of transition metals or cores, respectively. Generally a linking moiety comprises a substructure covalently linked to an alkyl or cycloalkyl group, comprising 1 to 20 carbon atoms, an aryl group comprising 1 to 5 phenyl rings, or an alkyl or aryl amine comprising alkyl or cycloalkyl groups having from 1 to 20 carbon atoms or aryl groups comprising 1 to 5 phenyl rings, and in which a linking cluster (e.g., a multidentate function groups) are
covalently bound to the substructure. A cycloalkyl or aryl substructure may comprise 1 to 5 rings that comprise either of all carbon or a mixture of carbon with nitrogen, oxygen, sulfur, boron, phosphorus, silicon and/or aluminum atoms making up the ring. Typically the linking moiety will comprise a substructure having one or more carboxylic acid linking clusters covalently attached. [0055] As used herein, a line in a chemical formula with an atom on one end and nothing on the other end means that the formula refers to a chemical fragment that is bonded to another entity on the end without an atom attached. Sometimes for emphasis, a wavy line will intersect the line.
[0056] In one embodiment, the linking moiety is selected from any of the following:
wherein
wherein X=I, 2, or 3. Further examples of ZIFs, MOFs, COFs and BOFs comprising linking moieties are set forth herein. [0057] A post framework reactant refers to any organic reactant . Rings of 1-20 carbons with functional groups comprising atoms such as N, S, 0, and P are useful. In addition, metal and metal containing compounds that may chelate to and add functional groups or a combination of previously existing and newly added functional groups are also useful. Reactions that result in the' tethering of organometallic complexes to the framework for use as, for example, a heterogeneous catalyst can be used. For example, converting a reactive side group in a linking agent to an alcohol followed by reacting the group with an alkali earth metal to generate a metal alkoxide is provided.
[0058] Examples of post framework reactants include, but are not limited to, heterocyclic compounds. In one embodiment, the post framework reactant can be a saturated or unsaturated heterocycle. The term "heterocycle" used alone or as a suffix or prefix, refers to a ring-containing structure or molecule having one or more multivalent heteroatoms, independently selected from N, 0 and S, as a part of the ring structure and including at least 3 and up to about 20 atoms in the ring(s). Heterocycle may be saturated or unsaturated, containing one or more double bonds, and heterocycle may contain more than one ring. When a heterocycle- contains more than one ring, the rings may be fused or unfused. Fused rings generally refer to at least two rings share two atoms there between. Heterocycle may have aromatic character or may not have aromatic character. The terms "heterocyclic group", "heterocyclic moiety", "heterocyclic", or "heterocyclo" used alone or as a suffix or prefix, refers to a radical derived from a
heterocycle by removing one or more hydrogens there from. The term "heterocyclyl" used alone or as a suffix or prefix, refers a monovalent radical derived from a heterocycle by removing one hydrogen there from. The term "heteroaryl" used alone or as a suffix or prefix, refers to a heterocyclyl having aromatic character. Heterocycle includes, for example, monocyclic heterocycles such as: aziridine, oxirane, thiirane, azetidine, oxetane, thietane, pyrrolidine, pyrroline, imidazolidine, pyrazolidine, pyrazoline, dioxolane, sulfolane 2, 3-dihydrofuran, 2, 5-dihydrofuran tetrahydrofuran, thiophane, piperidine, 1,2,3,6- tetrahydro-pyridine, piperazine, morpholine, thiomorpholine, pyran, thiopyran, 2, 3-dihydropyran, tetrahydropyran, 1, 4-dihydropyridine, 1,4-dioxane, 1,3-dioxane, dioxane, homopiperidine, 2,3,4,7- tetrahydro-lH-azepine homopiperazine, 1, 3-dioxepane, 4,7-dihydro- 1, 3-dioxepin, and hexamethylene oxide. For example, heterocycles useful in the methods of the disclosure include:
(heteroaryl groups) , for example, pyridine, pyrazine, pyrimidine, pyridazine, thiophene, furan, furazan, pyrrole, imidazole, thiazole, oxazole, pyrazole, isothiazole, isoxazole, 1,2,3- triazole, tetrazole, 1, 2, 3-thiadiazole, 1, 2, 3-oxadiazole, 1,2,4- triazole, 1, 2, 4-thiadiazole, 1, 2, 4-oxadiazole, 1, 3, 4-triazole, 1, 3, 4-thiadiazole, and 1, 3, 4-oxadiazole .
[0060] Additionally, heterocycle encompass polycyclic heterocycles, for example, indole, indoline, isoindoline, quinoline, tetrahydroquinoline, isoquinoline, tetrahydroisoquinoline, 1, 4-benzodioxan, coumarin, dihydrocoumarin, benzofuran, 2, 3-dihydrobenzofuran, isobenzofuran, chromene, chroman, isochroman, xanthene, phenoxathiin, thianthrene, indolizine, isoindole, indazole, purine, phthalazine, naphthyridine, quinoxaline, quinazoline, cinnoline, pteridine, phenanthridine, perimidine, phenanthroline, phenazine, phenothiazine, phenoxazine, 1, 2-benzisoxazole, benzothiophene, benzoxazole, benzthiazole, benzimidazole, benztriazole,
thioxanthine, carbazole, carboline, acridine, pyrolizidine, and quinolizidine .
[0061] In addition to the polycyclic heterocycles described above, heterocycle includes polycyclic heterocycles wherein the ring fusion between two or more rings includes more than one bond common to both rings and more than two atoms common to both rings. Examples of such bridged heterocycles include quinuclidine, diazabicyclo [2.2.1] heptane and 7-oxabicyclo [2.2.1] heptane. [0062] Heterocyclyl includes, for example, monocyclic heterocyclyls, such as: aziridinyl, oxiranyl, thiiranyl, azetidinyl, oxetanyl, thietanyl, pyrrolidinyl, pyrrolinyl, imidazolidinyl, pyrazolidinyl, pyrazolinyl, dioxolanyl, sulfolanyl, 2, 3-dihydrofuranyl, 2, 5-dihydrofuranyl, tetrahydrofuranyl, thiophanyl, piperidinyl, 1, 2, 3, 6-tetrahydro-pyridinyl, piperazinyl, morpholinyl, thiomorpholinyl, pyranyl, thiopyranyl, 2,3- dihydropyranyl, tetrahydropyranyl, 1, 4-dihydropyridinyl, 1,4- dioxanyl, 1, 3-dioxanyl, dioxanyl, homopiperidinyl, 2,3,4,7- tetrahydro-lH-azepinyl, homopiperazinyl, 1, 3-dioxepanyl, 4,7- dihydro-1, 3-dioxepinyl, and hexamethylene oxidyl . [0063] In addition, heterocyclyl includes aromatic heterocyclyls or heteroaryl, for example, pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, thienyl, furyl, furazanyl, pyrrolyl, imidazolyl, thiazolyl, oxazolyl, pyrazolyl, isothiazolyl, isoxazolyl, 1, 2, 3-triazolyl, tetrazolyl, 1, 2, 3-thiadiazolyl, 1,2,3- oxadiazolyl, 1, 2, 4-triazolyl, 1, 2, 4-thiadiazolyl, 1,2,4- oxadiazolyl, 1, 3, 4-triazolyl, 1, 3, 4-thiadiazolyl, and 1,3,4 oxadiazolyl .
[0064] Additionally, heterocyclyl encompasses polycyclic heterocyclyls (including both aromatic or non-aromatic), for example, indolyl, indolinyl, isoindolinyl, quinolinyl, tetrahydroquinolinyl, isoquinolinyl, tetrahydroisoquinolinyl, 1,4- benzodioxanyl, coumarinyl, dihydrocoumarinyl, benzofuranyl, 2,3- dihydrobenzofuranyl, isobenzofuranyl, chromenyl, chromanyl, isochromanyl, xanthenyl, phenoxathiinyl, thianthrenyl, indolizinyl, isoindolyl, indazolyl, purinyl, phthalazinyl, naphthyridinyl, quinoxalinyl, quinazolinyl, cinnolinyl, pteridinyl, phenanthridinyl, perimidinyl, phenanthrolinyl, phenazinyl,
phenothiazinyl, phenoxazinyl, 1, 2-benzisoxazolyl, benzothiophenyl, benzoxazolyl, benzthiazolyl, benzimidazolyl, benztriazolyl, thioxanthinyl, carbazolyl, carbolinyl, acridinyl, pyrolizidinyl, and quinolizidinyl .
[0065] In addition to the polycyclic heterocyclyls described above, heterocyclyl includes polycyclic heterocyclyls wherein the ring fusion between two or more rings includes more than one bond common to both rings and more than two atoms common to both rings. Examples of such bridged heterocycles include quinuclidinyl, diazabicyclo [2.2.1]heptyl; and 7-oxabicyclo [2.2.1] heptyl . [0066] In the methods of the disclosure a post reactive framework agent is contacted with a ZIF, MOF, COF, or BOF framework to functionally modify the framework including pore size, binding capacity (e.g., free reactive side groups, charge etc) . Accordingly, the ZIF, MOF, COF or BOF frameworks can be modified for a desired purpose or use by selecting a post reactive framework agent to generate the desired porosity, charge and the like. [0067] A "zeolitic framework," as used herein, refers to a framework of repeating cores having a zeolite-type structure. A zeolitic framework can comprise a structure as set forth in the Atlas of Zeolite Structure Types.
[0068] A "zeolitic imidizolate framework" or "ZIF" refers to a zeolitic framework comprising a zeolitic structure having an imidizole, imidizolate-derivative, or imidizolate linking moiety. [0069] A zeolitic frameworks can comprise a network of homogenous transition metal or heterogeneous transition metals linked by a homogenous or heterogeneous linking moiety. The zeolitic frameworks of the disclosure can comprise any of the networks currently defined in the Atlas of Zeolite Structure Types known in the literature as well as POZ. The zeolitic frameworks of the disclosure provide nanoporous structure useful for filtration, gas storage and the like, as more fully described herein. Using the methods of the disclosure the ZIFs can be modified post synthesis using a post reactive agent of the disclosure to change or modify the porosity or charge of the framework. [0070] The disclosure also provide a general synthesis of structures having zeolite framework topologies in which all
tetrahedral atoms are transition metals, and the linking moieties comprise organic linkers comprising nitrogen, sulfur or oxygen organic molecules (e.g., such as imidazolate (IM) units) . The organic linkers may be further functionalized to modify the cage size and pore size or specificity to a guest species or gas molecule .
[0071] Zeolitic frameworks comprise the general structure M-L- M, wherein M comprises a transition metal and L is a linking moiety. In one embodiment, the framework comprising and M-L-M structure is selected from the group consisting of:
(a) M-L-M, wherein L comprises structure III; and
(b) M-L-M, wherein at least one L is structure III and at least one other L is a structure I, II or a combination thereof:
wherein A can be either C or N, wherein R5-R8 are present when A1 and A4 comprise C, wherein R1, R4 or R9 comprise a non-sterically hindering group that does not interfere with M, wherein R2, R3, R5, R8, R10, R11, R12 are each individually an alkyl, halo-cyano-nitro-,
wherein when the linking moiety comprises structure III, R10, R11 and R12 are each individually electron withdrawing groups, and wherein one of R6 and R7 comprise an electron withdrawing group. [0072] In one embodiment, R1, R4 or R9 comprise a non-sterically hindering electron donating group that does not interfere with M. The R1, R4 or R9 functionalized with a group selected to interact with a particular gas or substrate. In another embodiment, R2, R3, R6, R7, or R11 are individually H or a small electron withdrawing group. In one aspect, the small electron withdrawing group is of sufficient size to increase a cage size for a ZIF of the disclosure. For example, R7 can be a chloro- group. [0073] In a further embodiment the imidazolate or imidazolate derivative is selected from the group consisting of IV, V, VI, VII, VIII, and IX:
In one embodiment, the imidazolate or imidazolate derivative is selected from the group consisting of a substituted imidazolate; a benzimidazolate comprising a methyl-, nitro-, cyano, or chloro- group; an azabenzimidazolate; and an azabenzimidazolate wherein one or two carbon atoms on the benzimidazolate are replaced by nitrogen. The transition metal is selected from the group consisting of Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Y, Zr, Nb, Mo,
Tc, Ru, Rh, Pd, Ag, Cd, Lu, Hf, Ta, W, Re, Os, Ir, Pt, Au, Hg, Lr, Rf, Db, Sg, Bh, Hs, Mt, Ds, Rg and Uub. In one aspect, a zeolitic framework comprises a heterogeneous combination of transition metals. In yet another embodiment, the zeolitic framework comprises homogenous transition metal but a heterogeneous combination of linking moieties. In a further embodiment, a zeolitic framework comprises a heterogeneous mixture of transition metals and linking moieties.
[0074] In yet another embodiment, the linking moiety comprises a benzimidazolate (bIM) functionalized at the 5 or 4 and 5 positions to modify the pore character and/or cage structure of the framework. The functionalization moiety is used to increase the IM girth and comprises a small electron withdrawing group. The functionalization moiety can comprise, for example, a chloro-, brormo-, iodo- or fluoro-containing group. For example, the disclosure provides a 5-chlorobenzimidazolate (cbIM) linked to a transition metal selected from the group consisting of Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Y, Zr, Nb, Mo, Tc, Ru, Rh, Pd, Ag, Cd, Lu, Hf, Ta, W, Re, Os, Ir, Pt, Au, Hg, Lr, Rf, Db, Sg, Bh, Hs, Mt, Ds, Rg and ϋub . In one aspect, the cbIM linking moiety is linked to a Zn or Co transition metal.
[0075] In one embodiment, the imidazolate or imadazolate derivative linking moiety (metal groups not depicted) has a structure selected from the group consisting of:
[0076] In one embodiment, the linking moiety of the disclosure can comprise substituted or unsubstituted aromatic rings, substituted or unsubstituted heteroaromatic rings, substituted or unsubstituted nonaromatic rings, substituted or unsubstituted nonaromatic heterocyclic rings, or saturated or unsaturated, substituted or unsubstituted, hydrocarbon groups. The saturated or unsaturated hydrocarbon groups may include one or more heteroatoms . For example, the linking moiety substructure can comprise Formula XI:
wherein R1, R2, R3, and R4 are each independently H, alkyl, aryl, OH, alkoxy, alkenes, alkynes, phenyl and substitutions of the
foregoing, sulfur-containing groups (e.g., thioalkoxy) , silicon- containing groups, nitrogen-containing groups (e.g., amides), oxygen-containing groups (e.g., ketones, and aldehydes), halogen, nitro, amino, cyano, boron-containing groups, phosphorus-containing groups, carboxylic acids, or esters.
[0077] In one embodiment, the linking group comprises a structure selected from the group consisting of:
wherein the carboxylic acid groups above undergo a condensation with a transition metal to form a framework and wherein R1, R2, R3/ R4 = NH2, CN, OH, =0, =S, SH, P, Br, CL, I, F,
[0078] In another variation of the linking moiety is described by Formula XII:
wherein Ri, R2, R3, R4/ R5, and Re are each independently H, alkyl, aryl, OH, alkoxy, alkenes, alkynes, phenyl and substitutions of the foregoing, sulfur-containing groups (e.g., thioalkoxy) , silicon- containing groups, nitrogen-containing groups (e.g., amides), oxygen-containing groups (e.g., ketones, and aldehydes), halogen, nitro, amino, cyano, boron-containing groups, phosphorus-containing groups, carboxylic acids, or esters. In one aspect, Ri, R2, R3, R4 are each independently selected from the group consisting of NH2,
[0079] In another variation the linking moiety is described by
Formula XIII-XVI:
and Rχ6 are each independently H, alkyl, aryl, OH, alkoxy, alkenes,
alkynes, phenyl and substitutions of the foregoing, sulfur- containing groups (e.g., thioalkoxy) , silicon-containing groups, nitrogen-containing groups (e.g., amides), oxygen-containing groups (e.g., ketones, and aldehydes), halogen, nitro, amino, cyano, boron-containing groups, phosphorus-containing groups, carboxylic acids, or esters and T is a tetrahedral atom (e.g., carbon, silicon, germanium, tin) or a tetrahedral group or cluster. In one aspect, Ri, R2, R3, R4 are each independently selected from the group consisting of NH2, CN, OH, =0, =S, SH, P, Br, CL, I, F,
[0080] In another variation the linking moiety is described by
Formula XVII:
wherein Ai, A2, A3, A4, A5, and A6 are .each independently absent or any atom or group capable of forming a sable ring structure and R1, R2, R3, R4, R5, R6, R7, Rδ, R9, Rio/ Rn, and Ri2 are each independently H, alkyl, aryl, OH, alkoxy, alkenes, alkynes, phenyl and substitutions of the foregoing, sulfur-containing groups (e.g., thioalkoxy), silicon-containing groups, nitrogen-containing groups
(e.g., amides), oxygen-containing groups (e.g., ketones, and aldehydes), halogen, nitro, amino, cyano, boron-containing groups, phosphorus-containing groups, carboxylic acids, or esters. In one aspect, Ri, R2, R3, R4 are each independently selected from the group consisting of NH2, CN, OH, =0, =S, SH, P, Br, CL, I, F,
wherein X=I, 2, or -3. Specific examples of Formula XVII are provided by Formulae XVIII and XIX and ammonium salts of the linking groups of Formulae XVIII and XIX:
wherein R
and R12 are each independently H, alkyl, aryl, OH, alkoxy, alkenes, alkynes, phenyl and substitutions of the foregoing, sulfur-containing groups (e.g., thioalkoxy) , silicon-containing groups, nitrogen-containing groups (e.g., amides), oxygen-containing groups (e.g., ketones, and aldehydes), halogen, nitro, amino, cyano, boron-containing groups, phosphorus-containing groups, carboxylic acids, or esters. In one aspect, Ri, R2, R3, R4 are each independently selected from the group consisting of
[0081] In yet another variation the linking moiety is described by Formula XX :
wherein R1 through R12 are each independently H, alkyl, aryl, OH, alkoxy, alkenes, alkynes, phenyl and substitutions of the foregoing, sulfur-containing groups (e.g., thioalkoxy) , silicon- containing groups, nitrogen-containing groups (e.g., amides), oxygen-containing groups (e.g., ketones, and aldehydes), halogen, nitro, amino, cyano, boron-containing groups, phosphorus-containing groups, carboxylic acids, or esters; and n is an integer greater than or equal to 1. In one aspect, R1, R2, R3, R4 are each independently selected from the group consisting of NH2, CN, OH, =0, =S, SH, P, Br, CL, I, F,
[0082] A framework can undergo post synthetic modification by reacting the framework with a reactive specie. For example, if R2 of Formula XI is NH2 reaction with an aziridine containing compound results in opening of the reactive species ring depicted generally by:
[0083] Using such methods variations and functionalized frameworks can be generated. As shown above, the reaction of the linking moiety with a aziridine results in the addition of a side group to the linking moiety. In such a framework the reactive side group
can extend into the pores of the framework thereby modifying their size or charge.
[0084] The disclosure provides post synthesis functionalized frameworks (PRFs). PRFs comprise the general structure M-L-M wherein the transition metals or cores are linked by a linking moiety that comprises a side group useful for post synthesis modification .
[0085] The PRFs can comprise any of the types assigned by X-ray analysis to the ABW, AGO, AEI, AEL, AEN, AET, AFG, AFI, AFN, AFO, AFR, AFS, AFT, AFX, AFY, AHT, ANA, APC, APD, AST, ATN, ATO, ATS, ATT, ATV, AWO, AWW, BEA, BIK, BOG, BPH, BRE, CAN, CAS, CFI, CGF, CGS, CHA, CHI, CLO, CON, CZP, DAC, DDR, DFO, DFT, DOH, DON, EAB, EDI, EMT, EPI, ERI, ESV, EUO, FAU, FER, GIS, GME, GOO, HEU, IFR, ISV, ITE, JBW, KFI, LAU, LEV, LIO, LOS, LOV, LTA, LTL, LTN, MAZ, MEI, MEL, MEP, MER, MFI, MFS, MON, MOR, MSO, MTF, MTN, MTT, MTW, MWW, NAT, NES, NON, OFF, OSI, PAR, PAU, PHI, RHO, RON, RSN, RTE, RTH, RUT, SAO, SAT, SBE, SBS, SBT, SFF, SGT, SOD, STF, STI, STT, TER, THO, TON, TSC, VET, VFI, VNI, VSV, WIE, WEN, YUG and ZON structure and to mixed structures of two or more of the above mentioned structures.
[0086] Useful transition metal comprise any one or more of the following: Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Y, Zr, Nb, Mo, Tc, Ru, Rh, Pd, Ag, Cd, Lu, Hf, Ta, W, Re, Os, Ir, Pt, Au, Hg, Lr, Rf, Db, Sg, Bh, Hs, Mt, Ds, Rg, and Uub. In a specific embodiment, the transition metal is Zn or Co.
[0087] The framework (e.g., a PRF) of the disclosure can take any framework/structure. For example, using the methods of the disclosure, ZIFs having any of the following framework codes can be Obtained: ABW, ACO, AEI, AEL, AEN, AET, AFG, AFI, AFN, AFO, AFR, AFS, AFT, AFX, AFY, AHT, ANA, APC, APD, AST, ASV, ATN, ATO, ATS, ATT, ATV, AWO, AWW, BCT, BEA, BEC, BIK, BOG, BPH, BRE, CAN, CAS, CDO, CFI, CGF, CGS, CHA, CHI, CLO, CON, CZP, DAC, DDR, DFO, DFT, DOH, DON, EAB, EDI, EMT, EON, EPI, ERI, ESV, ETR, EUO, EZT, FAR, FAU, FER, FRA, GIS, GIU, GME, GON, GOO, HEU, IFR, IHW, ISV, ITE, ITH, ITW, IWR, IWV, IWW, JBW, KFI, LAU, LEV, LIO, LIT, LOS, LOV, LTA, LTL, LTN, MAR, MAZ, MEI, MEL, MEP, MER, MFI, MFS, MON, MOR, MOZ, MSE, MSO, MTF, MTN, MTT, MTW, MWW, NAB, NAT, NES, NON, NPO,
NSI, OBW, OFF, OSI, OSO, OWE, PAR, PAU, PHI, PON, POZ, RHO, RON, RRO, RSN, RTE, RTH, RUT, RWR, RWY, SAO, SAS, SAT, SAV, SBE, SBS, SBT, SFE, SFF, SFG, SFH, SFN, SFO, SGT, SIV, SOD, SOS, SSY, STF, STI, STT, SZR, TER, THO, TON, TSC, TUN, UEI, UFI, UOZ, USI, UTL, VET, VFI, VNI, VSV, WEI, WEN, YUG, and ZON.
[0088] A framework of the disclosure, such as a ZIF, can be synthesized by using solvothermal methods. Highly crystalline materials are obtained by combining the requisite hydrated metal salt (e.g., nitrate) and, for example, an imidazole-type linker in an amide solvent such as N,N-diethylformamide (DEF) . The resulting solutions are heated (85-15OºC) and zeolitic frameworks of the disclosure are precipitated after 48-96 h and were readily isolated.
[0089] The disclosure also provides covalently linked organic frameworks (COFs) . Typically in a COF each linking moiety is linked to at least one, typically two, distinct linking moieties. In a further refinement these COFs are crystalline materials that may be either polycrystalline or even single crystals. The linking moiety may be the same throughout the net (i.e., a homogenous net) or may be different or alternating types of multidentate cores (i.e., a heterogeneous net; in this aspect the denticity refers to the number of neighboring cores to which a particular core is bound) . Since the covalently bonded organic frameworks are extended structures, variation may form into analogous nets to the nets found in metallic organic frameworks as described in Reticular Chemistry: Occurrence and Taxonomy of Nets and Grammar for the Design of Frameworks, Ace. Chem. Res. 2005, 38, 176-182. The entire disclosure of this article is hereby incorporated by reference. [0090] The disclosure provides a covalent organic framework comprising two or more organic linking moieties covalently bonded to a linking cluster, the linking cluster comprising an identifiable association of 2 or more atoms, wherein the covalent bonds between each linking moiety and the linking cluster take place between atoms selected from carbon, boron, oxygen, nitrogen and phosphorus and at least one of the atoms in each covalent bond between a linking moiety and the linking cluster is oxygen. One or
more COFs can be covalently bonded to one another each COF can be identical or different in structure.
[0091] The covalently linked organic frameworks or polyhedra of the disclosure optionally further comprise a guest species. Such a guest species may increase the surface area of the covalently linked organic networks. In a similar manner, the covalentlV linked organic networks of the disclosure further comprise an adsorbed chemical species. Such adsorbed chemical species include for example, ammonia, carbon dioxide, carbon monoxide, hydrogen, amines, methane, oxygen, argon, nitrogen, organic dyes, polycyclic organic molecules, metal ions, inorganic clusters, organometallic clusters, and combinations thereof. In one aspect, the linking moiety further comprises a side group selected from the group consisting of
wherein X=I, 2, or 3 in addition to the linking cluster. Such side groups are useful for post-synthetic modification of the COF framework using reactive species such as a heterocycle as described above .
[0092] A method for forming a covalently linked organic frameworks and polyhedra set forth above is provided. In one variation of this embodiment, the method utilizes a linking moiety comprising at least one boron-containing cluster for use in condensation into an extended crystalline materials. Such linking moiety comprises a boron-containing cluster that self-condenses with other linking moieties. In another aspect, a first linking moiety comprising a boron-containing cluster is condensed with a linking moiety lacking a boron-containing cluster. The crystalline product may be either polycrystalline or single crystal. For
example, the condensation forms a porous, semicrystalline to crystalline organic materials with high surface areas. [0093] Schemes I and II below show methods for synthesizing 3D and 2D COFs of the disclosure, it is to be understood that each of the rings can comprise additional side groups. In accordance with Scheme 2, the dehydration reaction between phenylboronic acid and 2, 3, 6, 7, 10, 11-hexahydroxytriphenylene ("HHTP"), a trigonal building block, gives a new 5-membered BO2C2 ring.
[0094] Scheme 2 provides an example of the reaction of BDBA with TBST to form a 3-connected sheet. In an analogous manner as set forth above, the aromatic rings of both the starting materials and products of Scheme 2 are optionally substituted with alkyl, OH, alkoxy, sulfur-containing groups (e.g., thi'oalkoxy) , silicon-
containing groups, halogen, nitro, amino, cyano, boron-containing groups, phosphorus-containing groups, carboxylic acids, or esters. [0095] The COFs of the disclosure can take any framework/structure. For example, using the methods of the disclosure COFs having any of the following framework type codes can be obtained: ABW ACO AEI AEL AEN AET AFG AFI AFN AFO AFR AFS AFT AFX AFY AHT ANA APC APD AST ASV ATN ATO ATS ATT ATV AWO AWW BCT *BEA BEC BIK BOG BPH BRE CAN CAS CDO CFI CGF CGS CHA CHI CLO CON CZP DAC DDR DFO DFT DOH DON EAB EDI EMT EON EPI ERI ESV ETR EUO EZT FAR FAU FER FRA GIS GIU GME GON GOO HEU IFR IHW ISV ITE ITH ITW IWR IWV IWW JBW KFI LAU LEV LIO LIT LOS LOV LTA LTL LTN MAR MAZ MEI MEL MEP MER MFI MFS MON MOR MOZ MSE MSO MTF MTN MTT MTW MWW NAB NAT NES NON NPO NSI OBW OFF OSI OSO OWE PAR PAU PHI PON RHO RON RRO RSN RTE RTH RUT RWR RWY SAO SAS SAT SAV SBE SOS SBT SFE SFF SFG SFH SFN SFO SGT SIV SOD SOS SSY STF STI STT SZR TER THO TON TSC TUN UEI UFI UOZ USI UTL VET VFI VNI VSV WEI WEN YUG ZON. [0096] A framework on the disclosure may be interpenetrating. Furthermore, where a framework comprises an adsorbed chemical species (e.g., ammonia, carbon dioxide, carbon monoxide, hydrogen, amines, methane, oxygen, argon, nitrogen, argon, organic dyes, polycyclic organic molecules, and combinations thereof) the species may be exchanged or removed prior to reaction with a post framework reactant of the disclosure. The resulting functionalized frameworks (e.g., PRFs) provide useful sensors, absorbent materials, drug delivery devices and the like.
[0097] Also provided are devices for the sorptive uptake of a chemical species. The device includes a sorbent comprising a PRF provided herein or obtained by the methods of the disclosure. The uptake can be reversible or non-reversible. In some aspects, the sorbent is included in discrete sorptive particles. The sorptive particles may be embedded into or fixed to a solid liquid- and/or gas-permeable three-dimensional support. In some aspects, the sorptive particles have pores for the reversible uptake or storage of liquids or gases and wherein the sorptive particles can reversibly adsorb or absorb the liquid or gas.
[0098] In some embodiments, a device provided herein comprises a storage unit for the storage of chemical species such as ammonia, carbon dioxide, carbon monoxide, hydrogen, amines, methane, oxygen, argon, nitrogen, argon, organic dyes, polycyclic organic molecules, and combinations thereof.
[0099] Also provided are methods for the sorptive uptake of a chemical species. The method includes contacting the chemical species with a sorbent that comprises a PRF provided herein. The uptake of the chemical species may include storage of the chemical species. In some aspects, the chemical species is stored under conditions suitable for use as an energy source. [00100] Also provided are methods for the sorptive uptake of a chemical species which includes contacting the chemical species with a device provided described herein.
[00101] Natural gas is an important fuel gas and it is used extensively as a basic raw material in the petrochemical and other chemical process industries. The composition of natural gas varies widely from field to field. Many natural gas reservoirs contain relatively low percentages of hydrocarbons (less than 40%, for example) and high percentages of acid gases, principally carbon dioxide, but also hydrogen sulfide, carbonyl sulfide, carbon disulfide and various mercaptans. Removal of acid gases from natural gas produced in remote locations is desirable to provide conditioned or sweet, dry natural gas either for delivery to a pipeline, natural gas liquids recovery, helium recovery, conversion to liquefied natural gas (LNG) , or for subsequent nitrogen rejection. CO2 is corrosive in the presence of water, and it can form dry ice, hydrates and can cause freeze-up problems in pipelines and in cryogenic equipment often used in processing natural gas. Also, by not contributing to the heating value, CO2 merely adds to the cost of gas transmission.
[00102] An important aspect of any natural gas treating process is economics. Natural gas is typically treated in high volumes, making even slight differences in capital and operating costs of the treating unit significant factors in the selection of process technology. Some natural gas resources are now uneconomical to produce because of processing costs. There is a continuing need for
improved natural gas treating processes that have high reliability and represent simplicity of operation.
[00103] In addition, removal of carbon dioxide from the flue exhaust of power plants, currently a ma]or source of anthropogenic carbon dioxide, is commonly accomplished by chilling and pressurizing the exhaust or by passing the fumes through a fluidized bed of aqueous amine solution, both of which are costly and inefficient. Other methods based on chemisorption of carbon dioxide on oxide surfaces or adsorption within porous silicates, carbon, and membranes have been pursued as means for carbon dioxide uptake. However, in order for an effective adsorption medium to have long term viability in carbon dioxide removal it should combine two features: (i) a periodic structure for which carbon dioxide uptake and release is fully reversible, and (11) a flexibility with which chemical functionalization and molecular level fine-tuning can be achieved for optimized uptake capacities. [00104] A number of processes for the recovery or removal of carbon dioxide from gas steams have been proposed and practiced on a commercial scale. The processes vary widely, but generally involve some form of solvent absorption, adsorption on a porous adsorbent, distillation, or diffusion through a semipermeable membrane.
EXAMPLES
[00105] The methods provided herein extended to zeolitic imidazolate frameworks (ZIFs) as well as other frameworks, which have unusual thermal and chemical stability, and thus are ideal platforms for performing useful organic transformations under strong reaction conditions. Methods of generating porous ZIFs, COFs, MOFs and BOFs are described herein. To perform the postsynthesis functionalization on crystals, solvent guest species in the as-synthesized ZIFs, COFs, MOFs and BOFs are removed by immersing the crystals in a polar solvent such as methanol, related alkanols (e.g., ethanol and butanol) and related compounds such as chloromethane and methoxymethane . The solvent is then evacuated. The links in the framework (e.g., the imidazolate-2-carboxaldehyde (ICA) links, which join tetrahedral zinc(II) centers in a ZIF) are reduced by NaBH4 to the corresponding alcohol derivative, and converted to an imine functionality in refluxmg methanol (Scheme
III). Despite these strong reaction conditions, the integrity of the ZIF structure and its crystallinity are maintained throughout the synthesis. The isolated ZIF derivatives indicate that those organic reactions proceeded in high conversions. In essence the success in achieving typical organic reactions in crystals of extended structures like ZIFs makes the idea of using the "crystal as a molecule" a reality and opens many opportunities for employing the arsenal of organic reactions in the covalent functionalization of extended structures.
[00106] A new crystalline ZIF structure (termed ZIF-90, Figure 1) was synthesized by heating a solution mixture of H-ICA and Zn(NO3)2 ■ 4H2O (3:2 mol ratio) in N, N-dimethylformamide (DMF) at 100 °C for 18 h. The same material can also be obtained by diffusion of a triethylamine and hexane solution into a DMF mixture of H-ICA and Zn (NO3) 2 ■ 4H2O at 25 °C for 24 h. Elemental analysis performed on guest free ZIF-90 gave the expected formula, Zn (C4H3N2O) 2.4 Crystals of as-synthesized ZIF-90 where examined by single crystal X-ray diffraction (XRD) techniques and the structure was found to be related to the sodalite topology (SiO2, sod, Figure IA-C) by replacing the Si and 0 with Zn(II) and ICA links, respectively. This leads to an expanded ZIF structure with large voids (Figure IB) and an extended 3-D ZIF structure with an aperture of 3.5 A in
diameter and a pore size of 11.2 A (Figure 1C) . To perform the postsynthesis functionalization on crystals of ZIF-90, its porosity and structural integrity were examined. Solvent guests in the as- synthesized form of ZIF-90 were removed by first immersing the crystals in methanol then evacuating (0.01 Torr) at 25 ºC for 24 h. The N2 adsorption isotherm for the resulting sample measured at 77 K (Figure 2) showed a steep rise in the low-pressure region indicating the permanent porosity of the ZIF-90 framework. [00107] The small step at higher pressure with a hysteresis loop is attributed to a slight constriction of the pores due to the presence of the aldehyde functionality on the ICA links. Nevertheless, this does not prevent access to the pores by N2 molecules, and thus the calculated Langmuir and BET surface areas from the adsorption data for ZIF-90 were 1320 and 1270 m2/g, respectively.
[00108] Thermogravimetric analysis on the evacuated framework of ZIF- 90 showed a plateau region of no significant weight loss in the temperature range 300-500 ºC. Furthermore, the high chemical stability of ZIF-90 was evidenced by the unaltered powder X-ray diffraction- (PXRD) patterns upon boiling the solid in water, toluene, and methanol for 24 h. To ensure that the bulk crystals of ZIF-90 possess aldehyde functionality, the solid state, 13C cross polarization magic angle spinning (CP/MAS) NMR and FTIR spectra were measured. The 13C CP/MAS NMR spectrum showed the expected resonances at 129, 150, and 178 ppm for the symmetrically equivalent 4- and 5-carbon atoms of the imidazolate, the 2-carbon atom of the imidazolate and the aldehyde carbon atom, respectively. A strong band at 1678 cm-1 (vCdO) observed in the FTIR spectrum provided further evidence for the presence of aldehyde in bulk ZIF- 90 samples.
[00109] Given the permanent porosity of ZIF-90 and its exceptional chemical stability, useful organic transformations were performed on its evacuated crystalline samples. Specifically, reduction of aldehyde to alcohol functionality was successfully achieved by reacting ZIF-90 with NaBH4 in methanol at 60 ºC for 24 h to give ZIF-91 (Scheme IIIB) . Remarkably, ZIF-91 maintained the high crystallinity of the parent framework (ZIF-90) as confirmed by
their coincident PXRD patterns (Figure 3) . The presence of the alcohol group in ZIF-91 bulk samples was revealed by 13C CP/MAS NMR spectroscopy. This showed the appearance of four imidazolate carbon atom resonances suggesting that two chemically distinct imidazolate links were present within the framework. Furthermore, the observation of peaks attributable to both aldehyde and alcohol functional groups indicated that reduction was incomplete. To quantify the extent of reduction, a sample of ZIF-91 was digested in 20% DC1/D2O and analyzed by solution IH NMR. Comparison between the integrated peak intensities of the reduced and unreduced imidazolate species indicated that approximately 80% conversion had been achieved. In addition, confirmation of covalent modification was demonstrated by electrospray ionization mass spectrometry performed on samples of digested ZIF-91. The observation of peaks at 95.2 and 97.3 m/z were consistent with the negative parent ions of the aldehyde and alcohol functionalized imidazole links, respectively.
[00110] It is worthy to note that porosity of ZIF crystals was maintained throughout the conversion reaction of ZIF-90 to ZIF-91 (surface area of ZIF-91: 1070 and 1010 m2g-1 for Langmuir and BET surface areas, respectively) . The observed slight decrease in surface area may be due to the smaller pore aperture of ZIF-91 relative to that of ZIF-90 (Figure 2) .
[00111] The chemical versatility of the aldehyde group was highlighted by performing another organic transformation on the ICA link of ZIF-90. Reaction of ZIF-90 with ethanolamine in methanol at 60 ºC gave ZIF-92 (Scheme IIIC) . Quantitative conversion to the imine was completed within three hours as verified by 13C CP/MAS NMR and FTIR. The 13C solid state NMR spectrum of ZIF-92 showed resonances at 154 and 60 ppm for the imine and methylene carbons and resonances at 149 and 128 ppm for the imidazolate carbon atoms. A complete absence of any resonances due to ZIF-90 confirmed the quantitative imine formation of ZIF-92. Additionally, the FTIR spectrum of ZIF-92 was devoid of the vCdO stretching frequency at 1678 cm"1 and showed the appearance of a peak at 1637 cm"1 due to the vCdN bond of the imine. As was the case for the conversion of ZIF-90 to ZIF-91, the high crystallinity of the ZIF structure was
maintained as evidenced by the PXRD pattern of ZIF-92 (Figure 3) . The presence of the imine functionality in ZIF-92 severely constricts the pore aperture and prevents N2 molecules from accessing the interior of the pores, as confirmed by its gas adsorption isotherm behavior (Figure 2) .
[00112] All reagents unless otherwise stated were obtained from commercial sources (Alfa Aesar, Cambridge isotope laboratories, Sigma Aldrich) and were used without further purification. Yields reported were unoptimized. Elemental microanalyses were performed on a Thermo Flash EA1112 combustion CHNS analyzer.
[00113] Synthetic procedure for ZIF-90. Solvothermal procedure. Single crystals of ZIF-90 were obtained by heating a solution of zinc nitrate tetrahydrate (Zn (NO3) 2 -4H2O) (0.054 g, 0.21 mmol) and imidazole-2-carboxaldehyde (0.029 g, 0.30 mmol) in N, N- dimethylformamide (DMF, 3 mL) for 18 h at 100 ºC. [00114] Vapor diffusion. Zinc nitrate tetrahydrate (Zn(NO3J2 -4H2O) (0.13 g, 0.50 mmol) and imidazole-2-carboxaldehyde (0.07 g, 0.75 mmol) in DMF (10 mL) was placed in a desiccator under an atmosphere of triethylamine (5 mL) in hexane (200 mL) . The reaction was allowed to sit at room temperature for 24 h. The crystalline powder obtained was filtered and washed with methanol (3 χ 5 mL) . The product was activated with methanol (3 x 10 mL) over a three-day period before being dried under vacuum (10~2 Torr) for 24 h at room temperature. Yield (0.08 g, 61.5%) CHN calculated for C8H6N4O2Zn: C, 37.60; H, 2.37; N, 21.92% Found: C, 37.63; H, 2.76; N, 20.48%.
[00115] Procedure for covalent post synthetic modification of ZIF-91 and ZIF-92 are as follows.
Dried ZIF-90 crystals (0.10 g, 0.39 mmol) were suspended in methanol (10 mL) and NaBH4 (0.06 g, 1.56 mmol), and refluxed for 24 h. The reaction mixture was filtered and the solid was washed 2-3 times with fresh methanol (20 mL) . The microcrystalline solid was further exchanged with fresh methanol (20 mL) for 24 h. The solid was dried under vacuum (10~2 Torr) for 24 h at room temperature. Yield (0.09 g, 89%), conversion 77 %. It is worth noting that higher conversion of ZIF-90 to ZIF-91 may be achieved through
reaction times exceeding 24 h, however, a reduction in crystallinity is observed.
[00116] ZIF-92 Zn(C6H8N3O)2. Dried ZIF-90 crystals (0.15 g, 0.59 irimol) was suspended in methanol (10 mL) and ethanolamine (0.11 mL, 1.76 mmol), and refluxed for 24 hours. The reaction mixture was filtered and the solid was washed 2-3 times with fresh methanol (20 mL) . The solid was further exchanged with fresh methanol (20 mL) for 24 h. The solid was dried under vacuum (10~2 Torr) for 24 h at room temperature. Yield (0.16 g, 80%), conversion 100%. [00117] Powder X-ray diffraction. Powder X-ray data were collected using a Bruker D8-Discover Θ-2Θ diffractometer in reflectance Bragg-Brentano geometry employing Ni filtered Cu Ka line focused radiation at 1600 W (40 kV, 40 mA) power and equipped with a Vantec Line detector. Radiation was focused using parallel focusing Gobel mirrors. The system was also outfitted with an anti- scattering shield that prevents incident diffuse radiation from hitting the detector, preventing the normally large background at 2Θ < 3. Samples were mounted on zero background sample holders by dropping powders from a wide-blade spatula and then leveling the sample with a razor blade.
[00118] Solid state 13C CP/MAS nuclear magnetic resonance spectroscopy. High resolution solid-state nuclear magnetic resonance (NMR) spectra were recorded at ambient pressure on a Bruker DSX-300 spectrometer using a standard Bruker magic angle- spinning (MAS) probe with 4 mm (outside diameter) zirconia rotors. The magic angle was adjusted by maximizing the number and amplitudes of the signals of the rotational echoes observed in the 79Br MAS FID signal from KBr. Cross-polarization with MAS (CP/MAS) was used to acquire 13C data at 75.47 MHz. The 1H and 13C ninety- degree pulse widths were both 4 ms . The CP contact time varied from 1.5 to 5 ms. High power two-pulse phase modulation (TPPM) IH decoupling was applied during data acquisition. The decoupling frequency corresponded to 72 kHz. The MAS sample-spinning rate was 10 kHz. Recycle delays between scans varied between 3 and 10 s, depending upon the compound as determined by observing no apparent loss in the 13C signal from one scan to the next. The 13C chemical shifts are given relative to tetramethylsilane as zero ppm,
calibrated using the methylene carbon signal of adamantane assigned to 37.77 ppm as secondary reference.
[00119] Thermalgravimetry . Samples were run on a TA instrument Q-500 series thermal gravimetric analyzer (TGA) with samples held in platinum plans under nitrogen. A 5 K/min ramp rate was used. [00120] Solution NMR 1H nuclear magnetic resonance spectroscopy. Solution nuclear magnetic resonance (NMR) spectra were obtained at ambient temperature using a Bruker 400 MHz instrument. The signals are presented relative to TMS as 0 ppm using the water peak as a secondary reference at 4.79 ppm. 2IF-90 and ZIF-91 were digested in (20% DCl /D2O) , this allowed for quantification of reduction in ZIF- 91. The relative integration of the aldehyde to alcohol peak in Figure 16 showed 77.1% conversion of aldehyde to alcohol. [00121] ESI mass spectrometry. Mass spectrometry data shown for ZIF-91 digested in a formic acid/water (5%, v/v) solution. Peak at m/z of 95.20 corresponds to the negative parent ion of the 2- carboxaldehyde imidazole and the peak at 97.3 corresponds to the negative parent ion of the alcohol functionalized imidazole. [00122] Gas adsorption measurements. Low pressure gas adsorption isotherms were measured volumetrically on an Autosorb-1 analyzer (Quantachrome Instruments) . A liquid nitrogen sample bath (77 K) was used for N2, Ar, and H2 isotherm measurements. The N2, Ar, H2 and He gases used were UHP grade. For measurement of the apparent surface areas (SLang), the Langmuir or BET method was applied using the adsorption branches of the N2 isotherms assuming a N2 cross- sectional area of 16.2 A2/molecule. The total pore volumes (Vp) were determined using the Dubinin-Raduskavich (DR) method. Table Sl. Summary ofthe porosity ofZiFs
[00123] Infrared Spectroscopy (IR) . FT-IR spectra of ZIF-90 and ZIF-92 were obtained as KBr pellets using Nicolet 400 Impact spectrometer, signals are given in wavenumbers (cm"1) . •
[00124] Single crystal X-ray diffraction data collection, structure solution and refinement procedures . General Data Collection and Refinement Procedures: Data were collected on a Bruker SMART APEXII three circle diffractometer equipped with a CCD area detector and operated at 1200 W power (40 kV, 30 mA) to generate Cu Ka radiation (λ = 1.5418 A) . The incident X-ray beam was focused and monochromated using Bruker Excalibur Gobel mirror optics. A crystal of ZIF-90 was mounted on a nylon CryoLoops (Hampton Research) with Paraton-N (Hampton Research) . [00125] Initial scans of each specimen were performed to obtain preliminary unit cell parameters and to assess the mosaicity (i.e. breadth of spots between frames) of the crystal to select the required frame width for data collection. In every case frame widths of 0.5° were judged to be appropriate and full hemispheres of data were collected using the Bruker APEX21 software suite to carry out overlapping φ and ω scans at three different detector (2Θ) settings (2Θ = 28, 60, 100°) . Following data collection, reflections were sampled from all regions of the Ewald sphere to redetermine unit cell parameters for data integration and to check for rotational twinning using CELL_NOW2. In no data collection was evidence for crystal decay encountered. Following exhaustive review of collected frames the resolution of the dataset was judged. Data were integrated using Bruker APEX2 V 2.13 software with a narrow frame algorithm and a 0.400 fractional lower limit of average intensity. Data were subsequently corrected for absorption by the program SADABS4. The absorption coefficient (μ) is 1.94 cm"1 for the ZIF reported in this paper. However it is noteworthy that μ is based on the atomic contents and this is uncertain for most ZIF structures. The precise solvent molecule content is not known due to the diffuse electron density. The space group determination and tests for merohedral twinning were carried out using XPREP3. In all cases, the highest possible space group was chosen
[00126] All structures were solved by direct methods and refined using the SHELXTL 975 software suite. Atoms were located from iterative examination of difference F-maps following least squares ' refinements of the earlier models. Final models were refined anisotropically (if the number of data permitted) until full
convergence was achieved. Hydrogen atoms were placed in calculated positions (C-H = 0.93 A) and included as riding atoms with isotropic displacement parameters 1.2-1.5 times Ueq of the attached C atoms. Modeling of electron density within the voids of the frameworks did not lead to identification of guest entities in this structure due to the disordered contents of the large pores in the frameworks. The problem, which is typical for highly porous crystals that contain solvent filled pores, lies in the raw data where observed strong (high intensity) scattering becomes limited to ~1.0 A at best, with higher resolution data sometimes present but weak (low intensity) . A common strategy for improving X-ray data, increasing the exposure time of the crystal to X-rays did not improve the quality of the high angle data in this case, as the intensity from the low angle data saturated the detector and minimal improvement in the high angle data was achieved. Additionally, diffuse scattering from the highly disordered solvent in the void spaces within the crystal and from the loop used to mount the crystal contributes to the background noise and the 'washing out' of high angle data. The only optimal crystals suitable for analysis were generally small and weakly diffracting, and unfortunately, larger crystals, which would usually improve the quality of the data, presented a lowered degree of crystallinity and attempts to optimize the crystal growing conditions for large high-quality specimens has not yet been fruitful. For ZIF-90, it was found that data collection at -173 °C was optimal for obtaining the best data. In such cases the modeling of the disordered guest entities becomes intractable because at the lower temperature they become frozen into highly disordered arrays. Thus, electron density within void spaces, which could not be assigned to any definite guest entity, was modeled as isolated oxygen and/or carbon atoms, and the foremost errors in all the models lies with assignment of guest electron density. To prove the correctness of the atomic positions in the framework the application of the SQUEEZE6 routine of A. Spek had been performed. The assignment and refinement of the metal-organic ZIF framework atoms was unambiguous, as judged by the resulting bond and angle metrics which are chemically accurate and precise values. All structures were examined using the Adsym
subroutine of PLAT0N7 to assure that no additional symmetry could be applied to the models. All ellipsoids in ORTEP diagrams are displayed at the 30 % probability level unless noted otherwise. For all structures we note that the elevated R-values are commonly encountered in MOF crystallography, for the reasons expressed above, by us and other research groups 8-17 ZIF-90 (SOD— Cubic) . [00127] Experimental and Refinement Details for ZIF-90. A red colored cubic crystal (0.18 x 0.16 * 0.16 mm3) of ZIF-90 (CCDC693596) was placed in a 0.7 mm diameter nylon CryoLoops (Hampton Research) with Paraton-N (Hampton Research) . The loop was mounted on a SMART APEXII three circle diffractometer equipped with a CCD area detector and operated at 1200 W power (40 kV, 30 mA) to generate Cu Ka radiation (λ = 1.5418 A) while being flash frozen to 100(2) K in a liquid N2 cooled stream of nitrogen. A total of 6067 reflections were collected of which 317 were unique and 308 of these were greater than 2σ(I) . The range of θ was from 1.91 to 40.66°. Analysis of the data showed negligible decay during collection. The structure was solved in the cubic I-43m space group, with Z = 2, using direct methods. Atom ZnI was refined anisotropically . All other non-hydrogen atoms were refined isotropically with hydrogen atoms generated as spheres riding the - coordinates of their parent atoms. ZIF-90 is composed of two 2- imidazole carboxaldehyde linker per Zn. The attempts made to model the guests (solvent molecules) did not lead to identification of guest entities in this structure due to the limited periodicity of the solvent molecules in the crystals. Since the solvent is neither bonded to the framework nor tightly packed into the voids, solvent disorder can be expected for the MOF structures. Thus, electron density within void spaces which could not be assigned to any definite guest entity was modeled as isolated carbon atoms, and the foremost errors in all the models lies with the assignment of guest electron density. To assess the correctness of the atomic positions in the framework, the application of the SQUEEZE routine of A. Spek has been performed. It should be noted that the precision of this model is low; however, the structure is reported to display the framework for ZIF-90 as isolated in the crystalline form. Other supporting characterization data (vide infra Materials and Methods)
are consistent with the crystal structure. Final full matrix least- squares refinement on F2 converged to Rl = 0.1447 (F >2σF) ) and wR2 = 0.3497 (all data) with GOF = 1.832. When only framework atoms are included in the latter structure factor calculation, the residual electron density in the F-map is located within the pores of ZIF- 90.
[00128] The disclosure shows that useful organic transformations can be performed on crystalline frameworks (e.g., ZIFs) without altering the original structural integrity. The fact that these reactions proceed to high conversions under the same reaction conditions required in solution realizes the idea of "crystals as molecules". Indeed the high porosity and openness of the ZIF structures provide the medium for these reactions and allow for chemical transformations to take place in precise and well-defined spatial arrangements.
Claims
1. A method of generating post-reactive framework (PRF) comprising : generating a porous framework comprising a ZIF, a COF, a MOF or a BOF wherein a linking moiety of the porous framework comprises one or more reactive side groups selected from the group consisting of NH2, CN, OH, =0, =S, SH, P, Br, CL, I, F,
2. The method of claim 1, wherein the porous framework comprises a general structure M-L-M, wherein the M is transitions metal and L is a linking moiety.
3. The method of claim 2, wherein L comprises a substructure covalently linked to an alkyl or cycloalkyl group, comprising 1 to 20 carbon atoms, an aryl group comprising 1 to 5 phenyl rings, or an alkyl or aryl amine comprising alkyl or cycloalkyl groups having from 1 to 20 carbon atoms or aryl groups comprising 1 to 5 phenyl rings and a a linking cluster covalently bound to the substructure.
4. The method of claim 2 or 3, wherein the linking moiety substructure is selected from any of the following:
5. The method of claim 1, wherein the post framework reactant comprises a ring structure of 1-20 carbons with functional groups comprising atoms such as N, S, 0, and P.
6. The method of claim 5, further comprising a metal and metal containing compounds that chelate to and add functional groups to the reactive side group.
7. The method of claim 6, wherein the post framework reactant undergoes reaction with the porous framework that results in the tethering of organometallic complexes to the framework.
8. The method of claim 5, 6, or 7, wherein the post framework reactant comprises a heterocyclic compound.
9. The method of claim 8, wherein the heterocyclic compound has one or more multivalent heteroatoms, independently selected from N, 0 and S, as a part of the ring structure.
10. The method of claim 8, wherein the heterocylic compound comprises a monocyclic heterocycle.
11. The method of claim 10, wherein the monocyclic heterocycle is selected from the group consisting of: aziridine, oxirane, thiirane, azetidine, oxetane, thietane, pyrrolidine, pyrroline, imidazolidine, pyrazolidine, pyrazoline, dioxolane, sulfolane 2,3- dihydrofuran, 2, 5-dihydrofuran tetrahydrofuran, thiophane, piperidine, 1, 2, 3, 6-tetrahydro-pyridine, piperazine, morpholine, thiomorpholine, pyran, thiopyran, 2, 3-dihydropyran, tetrahydropyran, 1, 4-dihydropyridine, 1,4-dioxane, 1,3-dioxane, dioxane, homopiperidine, 2, 3, 4, 7-tetrahydro-lH-azepine homopiperazine, 1, 3-dioxepane, 4, 7-dihydro-l, 3-dioxepin, and hexamethylene oxide .
13. The method of any one of claims 1-12, wherein the reaction is carried out under mild conditions with reagents that result in a modification of a reactive side group that fits with the pore size of the porous framework.
14. The method of claim 1, wherein the post reactive framework comprises a modification of the linker moiety comprising an aliphatic sulfonic acid group.
15. The method of claim 1, wherein a guest species is removed from the porous framework prior to reacting the framework with the post framework reactant .
16. A method of a producing a porous framework comprising producing an amine-containing MOF structure and reacting the amine-containing MOF structure with 2-methylaziridine or 1,3- propanesultone to generate a post reactive framework.
17. A PRF produced by the method of any of claims 1-16.
18. A gas sorption device comprising a PRF of claim 17.
19. A porous framework comprising a plurality of multidentate cores linked to one another by a linking moiety, the linking moiety comprising a side group selected from the group consisting of NH2, CN, OH, =0, =S, SH, P, Br, CL, I, F,
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09837990.2A EP2358726B1 (en) | 2008-12-18 | 2009-12-18 | Porous reactive frameworks |
US13/140,408 US9512145B2 (en) | 2008-12-18 | 2009-12-18 | Porous reactive framework |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13873208P | 2008-12-18 | 2008-12-18 | |
US61/138,732 | 2008-12-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010080618A2 true WO2010080618A2 (en) | 2010-07-15 |
WO2010080618A3 WO2010080618A3 (en) | 2010-10-14 |
Family
ID=42317078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/068731 WO2010080618A2 (en) | 2008-12-18 | 2009-12-18 | Porous reactive frameworks |
Country Status (3)
Country | Link |
---|---|
US (1) | US9512145B2 (en) |
EP (1) | EP2358726B1 (en) |
WO (1) | WO2010080618A2 (en) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102794115A (en) * | 2012-08-01 | 2012-11-28 | 大连理工大学 | Preparation method of metal organic framework ZIF-8 (zero insert force-9) film |
US8480792B2 (en) | 2007-07-17 | 2013-07-09 | The Regents Of The University Of California | Preparation of functionalized zeolitic frameworks |
US8540802B2 (en) | 2007-05-11 | 2013-09-24 | The Regents Of The University Of California | Adsorptive gas separation of multi-component gases |
US8691748B2 (en) | 2007-09-25 | 2014-04-08 | The Regents Of The University Of California | Edible and biocompatible metal-organic frameworks |
US8742152B2 (en) | 2011-02-04 | 2014-06-03 | The Regents Of The University Of California | Preparation of metal-catecholate frameworks |
US8841471B2 (en) | 2009-09-25 | 2014-09-23 | The Regents Of The University Of California | Open metal organic frameworks with exceptional surface area and high gas storage capacity |
US8852320B2 (en) | 2011-01-21 | 2014-10-07 | The Regents Of The University Of California | Preparation of metal-triazolate frameworks |
US8876953B2 (en) | 2009-06-19 | 2014-11-04 | The Regents Of The University Of California | Carbon dioxide capture and storage using open frameworks |
US8916722B2 (en) | 2009-06-19 | 2014-12-23 | The Regents Of The University Of California | Complex mixed ligand open framework materials |
US8946454B2 (en) | 2008-06-05 | 2015-02-03 | The Regents Of The University Of California | Chemical framework compositions and methods of use |
US9078922B2 (en) | 2011-10-13 | 2015-07-14 | The Regents Of The University Of California | Metal-organic frameworks with exceptionally large pore aperatures |
US9102609B2 (en) | 2010-07-20 | 2015-08-11 | The Regents Of The University Of California | Functionalization of organic molecules using metal-organic frameworks (MOFS) as catalysts |
CN107020387A (en) * | 2016-02-01 | 2017-08-08 | 北京化工大学 | A kind of method that normal temperature and pressure quickly prepares copper nano-wire-metal organic framework ZIF-8 composites |
CN107735156A (en) * | 2015-04-30 | 2018-02-23 | 利物浦大学 | Porous material |
US9978474B2 (en) | 2010-09-27 | 2018-05-22 | The Regents Of The University Of California | Conductive open frameworks |
US10035127B2 (en) | 2013-11-04 | 2018-07-31 | The Regents Of The University Of California | Metal-organic frameworks with a high density of highly charged exposed metal cation sites |
US10058855B2 (en) | 2015-05-14 | 2018-08-28 | The Regents Of The University Of California | Redox-active metal-organic frameworks for the catalytic oxidation of hydrocarbons |
US10087205B2 (en) | 2014-03-28 | 2018-10-02 | The Regents Of The University Of California | Metal organic frameworks comprising a plurality of SBUS with different metal ions and/or a plurality of organic linking ligands with different functional groups |
US10118877B2 (en) | 2014-12-03 | 2018-11-06 | The Regents Of The University Of California | Metal-organic frameworks for aromatic hydrocarbon separations |
US10287304B2 (en) | 2014-02-19 | 2019-05-14 | The Regents Of The University Of California | Acid, solvent, and thermal resistant metal-organic frameworks |
US10494386B2 (en) | 2014-03-18 | 2019-12-03 | The Regents Of The University Of California | Mesoscopic materials comprised of ordered superlattices of microporous metal-organic frameworks |
US10597408B2 (en) | 2015-11-27 | 2020-03-24 | The Regents Of The University Of California | Covalent organic frameworks with a woven structure |
US10821417B2 (en) | 2015-11-27 | 2020-11-03 | The Regents Of The University Of California | Zeolitic imidazolate frameworks |
CN114924072A (en) * | 2022-05-05 | 2022-08-19 | 伊莱瑞特(武汉)生物技术有限公司 | Confining liquid for enzyme label plate and application of confining liquid in TPO-Ab enzyme immunoassay |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102014985B1 (en) * | 2010-07-27 | 2019-08-27 | 삼성전자주식회사 | Composite, electrode catalyst including the same, manufacturing method thereof, and fuel cell using the same |
WO2012138419A1 (en) * | 2011-04-04 | 2012-10-11 | Georgia Tech Research Corporation | Mof nanocrystals |
WO2012138418A1 (en) | 2011-04-04 | 2012-10-11 | Georgia Tech Research Corporation | Zeolite ddr nanocrystals |
US8821616B2 (en) | 2011-04-04 | 2014-09-02 | Georgia Tech Research Corporation | Zeolite DDR nanoparticles |
US9375678B2 (en) * | 2012-05-25 | 2016-06-28 | Georgia Tech Research Corporation | Metal-organic framework supported on porous polymer |
US9994501B2 (en) | 2013-05-07 | 2018-06-12 | Georgia Tech Research Corporation | High efficiency, high performance metal-organic framework (MOF) membranes in hollow fibers and tubular modules |
US9687791B2 (en) | 2013-05-07 | 2017-06-27 | Georgia Tech Research Corporation | Flow processing and characterization of metal-organic framework (MOF) membranes in hollow fiber and tubular modules |
CN105294738B (en) * | 2015-10-27 | 2018-05-04 | 浙江工业大学 | Method for preparing metal organic framework material by conversion method |
WO2017184991A1 (en) | 2016-04-22 | 2017-10-26 | The Regents Of The University Of California | Post-synthetically modified metal-organic frameworks for selective binding of heavy metal ions in water |
CN107855109A (en) * | 2017-11-03 | 2018-03-30 | 商丘师范学院 | One kind improves the oxazolyl framework material of zeolites containing zinc CO2The method of absorption property |
CN109012243A (en) * | 2018-08-22 | 2018-12-18 | 南开大学 | The preparation and Separate Efficiency Study of macromolecule-covalent organic frame material (polyCOF) composite membrane |
CA3055359A1 (en) * | 2018-09-13 | 2020-03-13 | Acsynam Inc. | Hypergolic metal organic frameworks |
CN110117346B (en) * | 2019-05-07 | 2022-11-01 | 江西师范大学 | Preparation method of electroactive covalent organic framework material |
CN110787657B (en) * | 2019-10-04 | 2022-03-18 | 天津大学 | Preparation method of Pebax/MIL-101 mixed matrix membrane |
US11305256B2 (en) | 2019-12-19 | 2022-04-19 | King Fahd University Of Petroleum And Minerals | Hybrid zeolitic imidazolate framework and a method of capturing carbon dioxide |
CN111234210B (en) * | 2020-02-28 | 2022-05-13 | 青岛农业大学 | Covalent organic framework material with benzofuran structure, synthetic method and application |
CN111530437B (en) * | 2020-05-18 | 2023-10-20 | 河南中医药大学 | Sulfonic acid functionalized covalent organic framework magnetic composite material with mixed action mode and preparation method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070202038A1 (en) | 2006-02-28 | 2007-08-30 | The Regents Of The University Of Michigan | Preparation of functionalized zeolitic frameworks |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4532225A (en) | 1983-02-11 | 1985-07-30 | Mobil Oil Corporation | Preparation of metal-containing zeolite catalysts of increased stability and activity |
US5160500A (en) | 1985-10-21 | 1992-11-03 | Mobil Oil Corporation | Zeolite synthesis using an alcohol or like molecules |
DE102004009956A1 (en) | 2004-03-01 | 2005-09-29 | Eurofilters N.V. | Adsorbent for dust collection filter, dust collection filter and method for odor adsorption |
US5208335A (en) | 1991-03-19 | 1993-05-04 | Air Products And Chemicals, Inc. | Reversible oxygen sorbent compositions |
US5733505A (en) | 1995-03-14 | 1998-03-31 | Goldstein; Mark K. | Non-regenerating carbon monoxide sensor |
US5648508A (en) | 1995-11-22 | 1997-07-15 | Nalco Chemical Company | Crystalline metal-organic microporous materials |
BR0016676A (en) | 1999-12-23 | 2002-10-15 | Unilever Nv | Bleaching composition, and, bleaching methods and for preparing a bleaching composition |
US6501000B1 (en) | 2000-04-04 | 2002-12-31 | Exxonmobil Research And Engineering Company | Late transition metal catalyst complexes and oligomers therefrom |
JP2005506305A (en) | 2001-04-30 | 2005-03-03 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン | Isoreticular metal-organic structures applicable to gas storage, methods of forming them, and systematic design of their pore sizes and functional groups |
US20030078311A1 (en) | 2001-10-19 | 2003-04-24 | Ulrich Muller | Process for the alkoxylation of organic compounds in the presence of novel framework materials |
US6929679B2 (en) | 2002-02-01 | 2005-08-16 | Basf Aktiengesellschaft | Method of storing, uptaking, releasing of gases by novel framework materials |
US6624318B1 (en) | 2002-05-30 | 2003-09-23 | Basf Aktiengesellschaft | Process for the epoxidation of an organic compound with oxygen or an oxygen-delivering compounds using catalysts containing metal-organic frame-work materials |
US6893564B2 (en) | 2002-05-30 | 2005-05-17 | Basf Aktiengesellschaft | Shaped bodies containing metal-organic frameworks |
US7008607B2 (en) | 2002-10-25 | 2006-03-07 | Basf Aktiengesellschaft | Process for preparing hydrogen peroxide from the elements |
WO2004080889A2 (en) | 2003-03-06 | 2004-09-23 | University Of Massachusetts | Crystalline membranes |
JP4937749B2 (en) | 2003-05-09 | 2012-05-23 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | Implementation of methods to achieve special levels of surface area and porosity in crystals |
US7309380B2 (en) | 2003-06-30 | 2007-12-18 | Basf Aktiengesellschaft | Gas storage system |
US20050004404A1 (en) | 2003-07-03 | 2005-01-06 | Basf Akiengesellschaft | Process for the alkoxylation of monools in the presence of metallo-organic framework materials |
EP1689762A4 (en) | 2003-12-05 | 2009-08-05 | Univ Michigan | Metal-organic polyhedra |
US7411081B2 (en) | 2004-01-13 | 2008-08-12 | Basf Aktiengesellschaft | Process for preparing and organometallic framework material |
WO2006047423A2 (en) | 2004-10-22 | 2006-05-04 | The Regents Of The University Of Michigan | Covalently linked organic frameworks and polyhedra |
US7524444B2 (en) | 2004-11-09 | 2009-04-28 | Basf Aktiengesellschaft | Shaped bodies containing metal-organic frameworks |
DE102004061238A1 (en) | 2004-12-20 | 2006-06-22 | Basf Ag | Method for the enrichment of methane in methane containing gas mixtures comprises contacting the gas mixture with at least a sorbent containing a porous metal-organic structure material |
DE102005000938A1 (en) | 2005-01-07 | 2006-07-20 | Basf Ag | Adsorptive recovery of xenon from krypton-xenon mixed gas |
US7343747B2 (en) | 2005-02-23 | 2008-03-18 | Basf Aktiengesellschaft | Metal-organic framework materials for gaseous hydrocarbon storage |
ES2558536T3 (en) | 2005-04-07 | 2016-02-05 | The Regents Of The University Of Michigan Technology Management Wolverine Tower Office | High gas adsorption in a metal-organic frame with open metal sites |
WO2006116340A1 (en) | 2005-04-22 | 2006-11-02 | University Of South Florida | Zeolite-like metal organic frameworks (zmofs): modular approach to the synthesis of organic-inorganic hybrid porous materials having a zeolite like topology |
US7763767B2 (en) | 2005-05-04 | 2010-07-27 | Exxonmobil Chemicals Patents Inc. | Adsorption process with on-line adsorbent removal |
US7799120B2 (en) | 2005-09-26 | 2010-09-21 | The Regents Of The University Of Michigan | Metal-organic frameworks with exceptionally high capacity for storage of carbon dioxide at room-temperature |
DE102005054523A1 (en) | 2005-11-14 | 2007-05-16 | Basf Ag | Porous organometallic framework containing another polymer |
EP1963767A4 (en) | 2005-12-21 | 2010-03-03 | Uop Llc | The use of mofs in pressure swing adsorption |
CN101641152B (en) | 2007-01-24 | 2014-04-23 | 加利福尼亚大学董事会 | Crystalline 3d- and 2d-covalent organic frameworks |
WO2008140788A1 (en) | 2007-05-11 | 2008-11-20 | The Regents Of The University Of California | Adsorptive gas separation of multi-component gases |
TW200914115A (en) | 2007-05-14 | 2009-04-01 | Shell Int Research | Process for producing purified natural gas from natural gas comprising water and carbon dioxide |
EP2167511A4 (en) | 2007-07-17 | 2010-12-22 | Univ California | Preparation of functionalized zeolitic frameworks |
US8691748B2 (en) | 2007-09-25 | 2014-04-08 | The Regents Of The University Of California | Edible and biocompatible metal-organic frameworks |
US8440732B2 (en) * | 2008-03-25 | 2013-05-14 | Sabic Innovative Plastics Ip B.V. | Polymeric foams with nanocellular morphology and methods for making them |
WO2009149381A2 (en) | 2008-06-05 | 2009-12-10 | The Regents Of University Of California | Chemical framework compositions and methods of use |
-
2009
- 2009-12-18 EP EP09837990.2A patent/EP2358726B1/en not_active Not-in-force
- 2009-12-18 WO PCT/US2009/068731 patent/WO2010080618A2/en active Application Filing
- 2009-12-18 US US13/140,408 patent/US9512145B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070202038A1 (en) | 2006-02-28 | 2007-08-30 | The Regents Of The University Of Michigan | Preparation of functionalized zeolitic frameworks |
Non-Patent Citations (6)
Title |
---|
"Reticular Chemistry: Occurrence and Taxonomy of Nets and Grammar for the Design of Frameworks", ACC. CHEM. RES., vol. 38, 2005, pages 176 - 182 |
See also references of EP2358726A4 |
SRINIVASAN NATARAJAN ET AL., CURRENT OPINION IN SOLID STATE AND MATERIALS SCIENCE, June 2009 (2009-06-01), pages 46 - 53 |
WILLIAM MORRIS ET AL., J. AM. CHEM. SOC., vol. 130, no. 38, 2008, pages 12626 - 12627 |
ZHENQIANG WANG ET AL., ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 47, 9 June 2008 (2008-06-09), pages 4699 - 4702 |
ZHENQIANG WANG ET AL., J. AM. CHEM. SOC., vol. 129, no. 41, 2007, pages 12368 - 12369 |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8540802B2 (en) | 2007-05-11 | 2013-09-24 | The Regents Of The University Of California | Adsorptive gas separation of multi-component gases |
US8480792B2 (en) | 2007-07-17 | 2013-07-09 | The Regents Of The University Of California | Preparation of functionalized zeolitic frameworks |
US8691748B2 (en) | 2007-09-25 | 2014-04-08 | The Regents Of The University Of California | Edible and biocompatible metal-organic frameworks |
US8946454B2 (en) | 2008-06-05 | 2015-02-03 | The Regents Of The University Of California | Chemical framework compositions and methods of use |
US8876953B2 (en) | 2009-06-19 | 2014-11-04 | The Regents Of The University Of California | Carbon dioxide capture and storage using open frameworks |
US8916722B2 (en) | 2009-06-19 | 2014-12-23 | The Regents Of The University Of California | Complex mixed ligand open framework materials |
US8841471B2 (en) | 2009-09-25 | 2014-09-23 | The Regents Of The University Of California | Open metal organic frameworks with exceptional surface area and high gas storage capacity |
US9102609B2 (en) | 2010-07-20 | 2015-08-11 | The Regents Of The University Of California | Functionalization of organic molecules using metal-organic frameworks (MOFS) as catalysts |
US9978474B2 (en) | 2010-09-27 | 2018-05-22 | The Regents Of The University Of California | Conductive open frameworks |
US8852320B2 (en) | 2011-01-21 | 2014-10-07 | The Regents Of The University Of California | Preparation of metal-triazolate frameworks |
US8742152B2 (en) | 2011-02-04 | 2014-06-03 | The Regents Of The University Of California | Preparation of metal-catecholate frameworks |
US9669098B2 (en) | 2011-10-13 | 2017-06-06 | The Regents Of The University Of California | Metal-organic frameworks with exceptionally large pore aperatures |
US9078922B2 (en) | 2011-10-13 | 2015-07-14 | The Regents Of The University Of California | Metal-organic frameworks with exceptionally large pore aperatures |
CN102794115A (en) * | 2012-08-01 | 2012-11-28 | 大连理工大学 | Preparation method of metal organic framework ZIF-8 (zero insert force-9) film |
US10035127B2 (en) | 2013-11-04 | 2018-07-31 | The Regents Of The University Of California | Metal-organic frameworks with a high density of highly charged exposed metal cation sites |
US10287304B2 (en) | 2014-02-19 | 2019-05-14 | The Regents Of The University Of California | Acid, solvent, and thermal resistant metal-organic frameworks |
US10494386B2 (en) | 2014-03-18 | 2019-12-03 | The Regents Of The University Of California | Mesoscopic materials comprised of ordered superlattices of microporous metal-organic frameworks |
US10087205B2 (en) | 2014-03-28 | 2018-10-02 | The Regents Of The University Of California | Metal organic frameworks comprising a plurality of SBUS with different metal ions and/or a plurality of organic linking ligands with different functional groups |
US10118877B2 (en) | 2014-12-03 | 2018-11-06 | The Regents Of The University Of California | Metal-organic frameworks for aromatic hydrocarbon separations |
CN107735156A (en) * | 2015-04-30 | 2018-02-23 | 利物浦大学 | Porous material |
US10058855B2 (en) | 2015-05-14 | 2018-08-28 | The Regents Of The University Of California | Redox-active metal-organic frameworks for the catalytic oxidation of hydrocarbons |
US10597408B2 (en) | 2015-11-27 | 2020-03-24 | The Regents Of The University Of California | Covalent organic frameworks with a woven structure |
US10821417B2 (en) | 2015-11-27 | 2020-11-03 | The Regents Of The University Of California | Zeolitic imidazolate frameworks |
CN107020387A (en) * | 2016-02-01 | 2017-08-08 | 北京化工大学 | A kind of method that normal temperature and pressure quickly prepares copper nano-wire-metal organic framework ZIF-8 composites |
CN114924072A (en) * | 2022-05-05 | 2022-08-19 | 伊莱瑞特(武汉)生物技术有限公司 | Confining liquid for enzyme label plate and application of confining liquid in TPO-Ab enzyme immunoassay |
Also Published As
Publication number | Publication date |
---|---|
WO2010080618A3 (en) | 2010-10-14 |
US20110319630A1 (en) | 2011-12-29 |
EP2358726A2 (en) | 2011-08-24 |
EP2358726A4 (en) | 2012-08-01 |
EP2358726B1 (en) | 2017-08-02 |
US9512145B2 (en) | 2016-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2358726B1 (en) | Porous reactive frameworks | |
EP2443133A2 (en) | Organo-metallic frameworks and methods of making same | |
US8916722B2 (en) | Complex mixed ligand open framework materials | |
US20130131344A1 (en) | Organo-metallic frameworks derived from carbenophilic metals and methods of making same | |
EP3676273B1 (en) | Zirconium terephthalate-based metal organic framework with open metal sites | |
US8742152B2 (en) | Preparation of metal-catecholate frameworks | |
US9078922B2 (en) | Metal-organic frameworks with exceptionally large pore aperatures | |
US20120259117A1 (en) | Organo-metallic frameworks and methods of making same | |
KR20140015315A (en) | Preparation of metal-triazolate frameworks | |
EP2167511A2 (en) | Preparation of functionalized zeolitic frameworks | |
EP2114560A1 (en) | Crystalline 3d- and 2d-covalent organic frameworks | |
WO2007101241A2 (en) | Preparation of functionalized zeolitic frameworks | |
US10702850B2 (en) | Adsorbents with stepped isotherms for gas storage applications | |
EP2533898A2 (en) | Organo-metallic frameworks derived from carbenophilic metals and method of making same | |
AU2012212243A1 (en) | Preparation of metal-catecholate frameworks |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09837990 Country of ref document: EP Kind code of ref document: A2 |
|
REEP | Request for entry into the european phase |
Ref document number: 2009837990 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009837990 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13140408 Country of ref document: US |